angiotensin ii has been researched along with Cardiomyopathies, Primary in 132 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 16 (12.12) | 18.7374 |
| 1990's | 15 (11.36) | 18.2507 |
| 2000's | 35 (26.52) | 29.6817 |
| 2010's | 32 (24.24) | 24.3611 |
| 2020's | 34 (25.76) | 2.80 |
| Authors | Studies |
|---|---|
| Li, X; Li, Y; Liu, L; Liu, X; Shi, Q | 1 |
| Chen, Y; He, D; Huang, M; Yan, Y | 1 |
| Bai, WW; Gao, CH; Guo, BX; Jiang, F; Li, C; Liu, KY; Qin, WD; Wang, H; Zhang, MX | 1 |
| Cheng, Y; Chu, J; Lin, S; Lu, Z; Peng, J; Shen, A; Shen, Z; Wang, T; Wang, Y; Xie, L | 1 |
| Chen, Y; Dong, Z; Guo, Y; Jin, H; Li, X; Liu, X; Liu, Y; Song, J; Wang, N; Xu, Y; Zhang, M; Zhang, Z; Zhong, J | 1 |
| Ji, L; Liu, D; Liu, G; Liu, M; Ono, K; Wang, L; Wei, M; Yin, Y; Zhan, Y; Zheng, M; Zhou, X | 1 |
| Han, X; Hao, H; Li, C; Li, W; Li, Y; Liang, C; Liu, HE; Liu, S; Liu, Y; Luo, Y; Pan, Z; Su, M; Sun, LI; Wei, Y; Yan, S; Yuan, Y; Zhang, R; Zhao, X | 1 |
| Bai, F; Banks, TE; Rajapaksha, M; Wang, NP; Zhang, LH; Zhao, ZQ | 1 |
| Alharbi, HO; Barrington, C; Cameron, AJM; Chotani, S; Clerk, A; Cook, AC; Cooper, STE; Cull, JJ; Herbert, E; Marshall, JJT; Meijles, DN; Mohun, T; Parker, PJ; Priestnall, SL; Prin, F; Rackham, OJL; Siow, B; Snoeks, T; Stuckey, DJ; Suáarez-Bonnet, A; Vanyai, H; Zaw Thin, M | 1 |
| Cao, L; Cong, H; Du, X; Geng, J; Hu, Y; Wang, J; Zhang, R; Zhang, Y; Zhao, X; Zheng, L | 1 |
| Li, G; Liang, G; Liang, S; Luo, W; Sun, J; Wang, M; Yu, T; Zou, C | 1 |
| Chai, YF; Chen, XS; Gao, YL; Liu, CY; Liu, YC; Meng, XL; Shou, ST; Wang, SH; Wei, W | 1 |
| Chen, W; Han, L; Ji, H; Yu, L; Zhu, H | 1 |
| Chai, YF; Chen, XS; Cui, JR; Gao, YL; Liu, YC; Meng, XL; Shou, ST; Wang, SH; Wei, W | 1 |
| Du, Z; Hao, Y; Li, W; Liang, Z; Liu, Y; Tao, Y; Wang, J; Yan, X; Yang, Y; Yu, J; Yuan, Y; Zhao, X | 1 |
| Du, CX; Huang, CW; Ku, HC; Kuo, YH; Lee, SY | 1 |
| Kokkonen-Simon, K; Kovacs, A; Li, T; Matkovich, SJ; Matsiukevich, D; Oladipupo, SS; Ornitz, DM | 1 |
| Cho, S; Jeong, D; Lee, C | 1 |
| Chen, L; He, Z; Huang, Y; Li, Y; Lu, F; Lyu, F; Lyu, X; Mo, Q; Qin, Q; Xu, H | 1 |
| Bai, F; Bose, HS; James, EA; Sturdivant, K; Wang, NP; Zhang, WW; Zhao, ZQ; Zheng, RH | 1 |
| Hill, JA | 1 |
| An, X; Tan, A; Wang, L; Xia, Y; Xie, Y | 1 |
| Adami, E; Chen, X; Cook, SA; Corden, B; Ko, NSJ; Lim, WW; Schafer, S; Song, W; Su, L; Tee, NGZ | 1 |
| Aasen, T; Abdul Moin, NI; Abdul Wafi, S; Aboukameel, A; Abu-Bakar, N; Acharya, A; Ackermans, L; Adaramoye, O; Adarsh, KV; Adeosun, WA; Ahmad, NH; Ahmadi, F; Akanni, O; Akbar, M; Akbulak, RO; Akev, N; Akkaya, Ö; Al-Rashed, S; AlAbbad, S; Alabi, O; Alappat, BJ; Alcalá, S; Alcoutlabi, M; Aleppo, G; Alexander Ross, JB; Alexander, JH; Alexander, R; Alias, A; Alimba, C; Alken, FA; Allan, R; Alpers, M; Alsbou, EM; Amarasiri, SS; An, T; Anastasiadis, F; Anastassiadou, M; Anderson, KC; Andronikos, P; Anheyer, D; Annapurna, K; Anorlu, RI; Anten, MM; Anthopoulos, TD; Araujo-Castillo, RV; Aravamudhan, S; Arawwawala, LDAM; Arulsamy, N; Arunamata, A; Asghar, A; Asiri, AM; Aslanidou, T; Astrakhantseva, IV; Astutik, E; Attanayake, AP; Atwater, BD; Audureau, E; Augusto, S; Bakare, A; Banach, M; Bandelier, P; Banerjee, S; Barral, M; Bascuñán, J; Bates, FS; Bauer, NJC; Bayrak, BB; Beck, RW; Beckervordersantforth, J; Beeri, R; Begum, R; Beldi-Ferchiou, A; Bellingham, G; Ben-Tal, N; Bendib, I; Bergenstal, RM; Berger, MF; Bernasconi, G; Berry, S; Beuvon, F; Bi, WJ; Bi, Z; Bianconi, V; Bibi, I; Blank, BR; Bliemeister, E; Bobkowski, W; Bode, AM; Booth, CM; Bose, U; Boyd, K; Brancato, A; Brenmoehl, J; Brogi, E; Bronzo, P; Brooks, T; Brown, D; Brown, DN; Bruce, D; Buan, MEM; Bueno-Hernández, F; Bugielski, B; Bulavaitė, A; Buscagan, TM; Buxton, R; Caffaro, MM; Cai, Q; Cai, X; Cai, Y; Calhoun, P; Callander, N; Cambier, S; Camparo, P; Canales-Vargas, EJ; Canham, K; Cantu, J; Cao, J; Cao, JW; Cao, P; Cao, T; Cao, X; Caravella, BA; Carcadea, E; Carè, J; Carmichael, P; Carrasco Cabrera, L; Carteaux, G; Carvalho, PDS; Casarez, E; Cazorla, M; Celestrin, CP; Chakraborty, NK; Chan, B; Chandarlapaty, S; Chandgude, AL; Chang, CC; Chang, JH; Chang, X; Chang, Y; Chankhanittha, T; Chantanis, S; Chapovetsky, A; Chavan, S; Chen, B; Chen, D; Chen, F; Chen, G; Chen, H; Chen, J; Chen, K; Chen, KJ; Chen, KP; Chen, L; Chen, MA; Chen, Q; Chen, S; Chen, W; Chen, WF; Chen, X; Chen, Y; Cheng, D; Cheng, J; Cheng, Q; Cheon, GJ; Chiu, SC; Cho, CH; Cho, J; Choi, H; Choi, JS; Choi, YH; Christie, P; Chu, CH; Chu, Y; Chung, DH; Chung, F; Cline, JP; Cohen, A; Cohen, AD; Cohen, NJ; Comen, E; Compter, I; Cong, J; Cong, Z; Cooper, A; Cornud, F; Costa, C; Costa, S; Covey, A; Cowan, AM; Cramer, H; Cruz-Rivera, C; Cui, J; Cui, M; Cui, Y; Cui, YH; Culquichicón, C; Cushman, T; D'Auria, SJ; da Silva, J; Dalgediene, I; Danenberg, HD; Das, S; Dasgupta, K; Daubit, IM; de Oliveira, PD; de Prost, N; De Ruysscher, D; Dearman, K; Decato, D; Delfau-Larue, MH; Deng, L; Dhakate, SR; Dharuman, V; Di Costanzo, N; Dickler, MN; Dinehart, EE; Ding, D; Dinh, TK; Divya, KP; Djifack Tadongfack, T; Do, T; Domínguez-Roldan, R; Domínguez-Zambrano, E; Dömling, A; Donato, MD; Dong, JH; Dong, W; Dong, X; Dong, XR; Dong, Y; Dong, Z; Downs, M; Drutskaya, MS; Du, B; Du, F; Du, H; Du, L; Du, X; Duan, Z; Duangthip, D; Dunstand-Guzmán, E; Duong, F; Eckert, DJ; Edelhäuser, BAH; Eekers, DBP; Efendi, F; Efraimidis, P; Ehrenberg, H; Ehsanbakhsh, Z; Eickholt, C; Eksterowicz, J; El Mobadder, M; El-Araby, IE; El-Magd, MA; El-Tarabany, MS; Elgorban, AM; Engelmann, D; English, KL; Esfandiari, H; Eslami, B; Espinosa-Cuevas, A; Eswara, S; Faber, E; Fan, XH; Fan, Y; Fang, J; Fang, Z; Fantin, VR; Fei, P; Feng, G; Feng, H; Feng, J; Feng, X; Feng, XJ; Fennell, TR; Fernández-Moreira, V; Ferraz, ABF; Ferreras, KN; Flores, K; Flores-Pérez, I; Flox, C; Fluharty, FL; Fokouong Tchoffo, E; Folefack, GO; Foroutan, T; Fort, D; Fourati, S; Fousas, S; Frapard, T; Freguia, S; Friedman, DJ; Friedman, LS; Fu, D; Fu, Q; Fu, Y; Fujinami, S; Furihata, K; Gal, RL; Gan, H; Gao, C; Gao, F; Gao, R; Gao, SS; Gao, W; Gao, XC; Gao, Y; Gao, Z; Garozi, L; Ge, J; Georgiopoulos, A; Gerakiou, K; Ghazimirsaeed, SM; Ghazimirsaeed, ST; Gimeno, MC; Gjestad, R; Glurich, I; Goetchius, E; Goland, S; Goldstein, S; Gonçalves, CM; Gonçalves, H; Gong, Q; Gonzalez, D; Goplen, FK; Gorshkova, EN; Gotsman, I; Govindasamy, V; Granger, CB; Greco, L; Grigoriadou-Skouta, E; Grigoropoulos, P; Grivicich, I; Gromov, NV; Gruber, S; Grytczuk, M; Grzech-Leśniak, K; Gu, L; Gu, S; Gu, Z; Guadagnini, D; Guan, H; Guilliams, M; Guo, J; Guo, L; Gupta, A; Gupta, SK; Gurzu, S; Gutleb, AC; Haban, A; Hablitz, JJ; Hadisuyatmana, S; Hahn, S; Haiges, R; Hallal-Calleros, C; Hamed, M; Hammad, N; Hammer, N; Han, C; Hao, Y; Harnett, J; Has, EMM; Hassanpour, K; Hatzopoulos, D; Hawaldar, R; He, X; He, Y; He, YY; He, Z; Heberman, D; Heckl, D; Hegde, H; Henson, MA; Hernández-Velázquez, VM; Herrera, E; Hijazi, Z; Hirayama, K; Hirth, JM; Hoeben, A; Hohnloser, SH; Hong, M; Hood, K; Hoplock, LB; Hopman, WM; Horlbogen, LM; Hossein Rashidi, B; Hou, G; Hou, H; Hou, J; Hou, Y; Hu, J; Hu, W; Hu, X; Hua, W; Huang, G; Huang, H; Huang, J; Huang, T; Huang, W; Huang, Y; Huang, YD; Huang, Z; Hudis, CA; Hue, S; Huo, J; Hussain, M; Hvas, AM; Ichii, T; Ide Zeuna, J; Ilyas, S; Inoue, T; Iranzo, A; Irfan, M; Iwasa, Y; Iwashita, Y; Izgorodina, EI; J R, A; Jaber, WA; Jaborek, JR; Jacobus, SJ; Jadeja, SD; Jafarabadi, M; Jalan, D; Jamil, MI; Jarrah, S; Jarvis, D; Jayatilaka, KAPW; Jemal-Turki, A; Jeon, YK; Jeong, N; Jeong, SH; Jeong, SY; Jermy, M; Jhaveri, K; Ji, H; Ji, K; Ji, RY; Jiang, F; Jiang, J; Jiang, X; Jiang, Y; Jiao, Q; Jilani, K; Jiménez-Guerrero, P; Jin, L; Jo, YH; Johnson, JG; Johnson, ML; Jones, WS; Jose, S; Jularic, M; Jung, I; Jung, YJ; Jungen, C; Junttila, MR; Kache, S; Kahanovitch, U; Kalantzi, KI; Kallio, T; Kamnoedboon, P; Kang, CH; Kang, H; Kang, J; Kang, KW; Kapoor, P; Karmakar, D; Kartalis, A; Kauranen, P; Kazocina, A; Keikha, F; Keltai, M; Kershaw, SV; Kettani, M; Khalvati, S; Khandhar, S; Khosla, N; Kiely, CJ; Kim, CC; Kim, H; Kim, MJ; Kim, Y; Kim, YH; Kim, YT; Kimoto, E; Kiyu, A; Klatt, N; Kobayashi, M; Koh, J; Köhler, R; Kondadasula, SV; Kong, H; Kong, W; Kong, X; Kotidis, A; Kotwal, A; Kouvari, M; Kozhinov, AN; Kruger, D; Kuang, S; Kuang, Y; Kubota, M; Kuklik, P; Kumar, P; Kumar, SK; Kuo, YF; Kurup, SP; Kusuhara, H; Kuswanto, H; Lacouture, ME; Lambin, P; Lang, CC; Langroudi, FH; Lanman, RB; Larsen, OH; Laskin, J; Le, VH; Leach, M; Lee, BG; Lee, DF; Lee, DS; Lee, HJ; Lee, SB; Lee, YA; Lei, Y; Lekashvili, O; Lelj, F; Lemin, AS; Lemoine, J; Leuschner, R; Li, B; Li, BT; Li, C; Li, D; Li, F; Li, G; Li, H; Li, HW; Li, J; Li, M; Li, P; Li, Q; Li, S; Li, W; Li, X; Li, XY; Li, Y; Li, Z; Lian, Y; Liang, C; Liao, J; Liao, W; Liao, Y; Lin, D; Lin, W; Lin, YL; Lindbäck, J; Lindsay, AP; Ling, J; Linser, PJ; Liu, C; Liu, H; Liu, JJ; Liu, L; Liu, Q; Liu, SF; Liu, X; Liu, Y; Liu, Z; Liu, ZM; Lo Sterzo, C; Lo, ECM; Lobchuk, MM; Lodge, TP; Logotheti, S; Lonial, S; Lopes, G; Lopes, RD; Lopez, J; Lopez, SA; López-Santos, AL; López-Sendón, JL; Loring, Z; Louis, C; Lovita, AND; Lu, DZ; Lu, H; Lu, J; Lu, K; Lu, TT; Lu, Y; Luengo, A; Lum, LG; Luna, JM; Luo, L; Luo, R; Luo, T; Luo, X; Luo, Z; Lv, B; Lymperopoulos, N; Lyras, A; Lyu, Y; M Kannan, A; Ma, H; Ma, M; Ma, Q; Ma, S; Ma, WY; Ma, Y; Maalouf, E; Machado, FA; Maeda, K; Magrans, JO; Maharani, A; Maia, G; Mainwaring, RD; Maji, TK; Majumdar, K; Mannarino, MR; Mansuri, MS; Marinescu, SC; Markatos, G; Marquardt, S; Marraiki, N; Martens, C; Martínez, TJ; Marumo, K; Maruyama, H; Marwani, HM; Marzo, I; Masrati, G; Matamba, P; Mathialagan, S; Matys, J; Mayatra, JM; Mboua, PC; McArthur, T; McCrimmon, RJ; McIntosh, S; McSpadden, S; Medina-Campos, ON; Medvedovsky, AT; Mei, Z; Mekontso-Dessap, A; Menezes, AMB; Meng, J; Meng, P; Meng, Y; Menter, A; Mets, MB; Mets-Halgrimson, R; Metzger, T; Metzler-Nolte, N; Meyer, C; Mi, Y; Michailoviene, V; Mikrogeorgiou, A; Militz, H; Miller Iii, TF; Minarowska, A; Mir, S; Miron, I; Miyake, T; Moayer, F; Modi, S; Moeller, SJ; Mohamad, MN; Mohammed, EHM; Mokhonov, VV; Mondal, A; Moore, J; Moravcova, M; Mordi, IR; Mordi, NA; Mortensen, NP; Moscariello, C; Moser, J; Moynahan, ME; Mu, J; Mu, W; Mudduwa, LKB; Mukherjee, S; Mukhtar, A; Mulkey, DK; Murr, N; Mushtaq, Z; Muthuswamy, N; Mutlu, O; Muto, C; Myroforou, I; Na, KJ; Nabi, M; Nagornov, KO; Nagy, RJ; Naik, A; Nakajima, K; Nam, KT; Nam, YW; Namburath, M; Nammour, S; Namour, A; Namour, M; Nanan, S; Natsume, H; Nave, S; Naveed, A; Nazir, H; Ndubaku, C; Nedospasov, SA; Neradilek, MB; Newcomb, C; Nguépy Keubo, FR; Nguyen, M; Ning, J; Ning, Q; Noguchi, S; Nordahl, SHG; Nordfalk, KF; Norton, L; Noupoue, EM; Nouri, SS; Nowak, JK; Núñez, K; Oakes, K; Odegaard, JI; Ogorodnikova, OL; Ogunsuyi, O; Oh, HK; Oh, HR; Oh, KH; Ohgi, K; Okunade, KS; Oliveira, AG; Olorunfemi, G; Olsen, ML; Olson, BA; Omari, KW; Ondruschka, B; Orfali, R; Orkopoulos, A; Orlowski, RZ; Oser, SM; Oser, TK; Özcan, M; Padilla, V; Paeng, JC; Pajuelo-Lozano, N; Pal, SK; Palmieri, S; Palomeque, E; Pan, W; Panagiotakos, DB; Pandey, M; Pang, D; Pang, Q; Pangarah, CA; Panny, A; Paparella, A; Papirio, S; Papouskova, K; Parang, K; Park, HJ; Park, IK; Park, S; Parker, TL; Parkhomenko, A; Parmon, VN; Parsons, B; Parsons, J; Patel, PR; Patil, S; Patsourakos, NG; Patterson, KC; Pavlidis, P; Pedernera, M; Pedersen, R; Pedraza-Chaverri, J; Pellegrini, M; Peña-Chora, G; Pereira, EDM; Pereira, MADS; Peretz, A; Perez-Padilla, R; Perlman, GY; Perona, R; Petras, C; Phuntsho, S; Picada, JN; Pinder, TA; Piper, LFJ; Pirozzi, F; Pirro, M; Pleckaityte, M; Ploutz-Snyder, LL; Ploutz-Snyder, R; Pogorzelski, A; Poles, L; Postma, AA; Prager, A; Prakash, J; Punn, R; Pützer, BM; Qi, J; Qi, MC; Qi, Y; Qian, J; Qian, Y; Qiang, L; Qiu, J; Qu, Y; Rabiu, KA; Rahighi, S; Rahman, MM; Rahmani, B; Rajkumar, SV; Ramanathan, R; Raras, TYM; Rashi, Y; Rasool, G; Rathore, MG; Ratnawati, R; Ratola, N; Raucci, U; Ray, SK; Razavi, P; Razazi, K; Razek, S; Razi, SS; Reback, M; Reddy, K; Rees, DC; Reginatto, FH; Reich, H; Reis-Filho, JS; Ren, X; Ren, Y; Renner, G; Rey, G; Reymen, B; Riaz, M; Ricci, A; Richardson, PG; Richter, C; Riga, M; Ritchie, C; Rivoal, S; Roberts, W; Robson, ME; Rocha, GZ; Rodrigues, AD; Rogach, AL; Rojas, A; Rosenberg, A; Rosenberg, E; Rosenheck, RA; Roslan, K; Rothenberger, C; Rouschop, KMA; Rubagumya, F; Ryan, CM; Ryder, JW; Saad, MJA; Sacan, O; Sacchi, A; Sahebkar, A; Saini, A; Sainz, B; Sajo, EA; Sakizadeh, J; Saleh, AA; Salgado Júnior, IB; Salvi, R; Samoylova, YV; Samuni, A; Sanchez, DM; Sanchez-Perez, I; Santos, M; Sarapulova, A; Sardot, T; Saud, N; Sauerbier, P; Scaltriti, M; Schaeffer, B; Schalk, DL; Scherschel, K; Schijven, MP; Schreuder, HWR; Schuhmacher, M; Schultz-Lebahn, A; Schwarzl, J; Scott, JM; Sebayang, SK; Seeger, ZL; Segabinazi Peserico, C; Selenica, P; Serio, A; Seruga, B; Shah, A; Shah, C; Shah, PD; Shahrokh Tehraninezhad, E; Shan, A; Shao, Z; Sharma, AMR; Sharma, RK; Shen, J; Shen, R; Shi, X; Shi, Y; Shi, ZE; Shih, YC; Shimohata, H; Shimpi, N; Shin, SH; Shon, HK; Shuvy, M; Siddique, AB; Siegbahn, A; Sikandar, M; Silvani, Y; Singh, A; Singh, AK; Singh, D; Singh, JS; Singh, KP; Singh, M; Situ, B; Skipper, MT; Skouloudi, M; Sloane, BF; Smyrnioudis, N; Snyder, MA; Söhnchen, C; Solis Condor, R; Solit, DB; Someya, S; Song, H; Song, J; Song, W; Song, Y; Sorokina, KN; Soshi, S; Soyer, P; Spitschak, A; Sreekrishnan, TR; Srinivasan, M; Staruschenko, A; Steel, A; Stefan-van Staden, RI; Stein, AM; Strayer, H; Struthers, AD; Su, H; Su, Q; Su, X; Sudore, RL; Sugimura, H; Sugiyama, Y; Sujuti, H; Sumner, SJ; Sun, B; Sun, D; Sun, H; Sun, J; Sun, JY; Sun, X; Sun, Y; Sun, Z; Sung, YC; Surenaud, M; Sutimantanapi, D; Suwandaratne, NS; Swaroop, S; Sychrova, H; Syed, A; Szczepanik, M; Szederjesi, J; Szodorai, R; Tacy, TA; Tadelle, RM; Takayasu, M; Tammeveski, K; Tan, H; Tan, M; Tang, HX; Tang, S; Tang, X; Tanokura, M; Tao, F; Tao, H; Tarafdari, A; Tarín-Carrasco, P; Tasson Tatang, C; Teixeira, JP; Thakur, A; Theobald, A; Thevenot, P; Thomaidis, K; Tian, J; Tillib, SV; Toma, C; Tomita, M; Tonchev, I; Tong, F; Toy, W; Trypuć, M; Tselepis, AD; Tsetseris, L; Tsikouri, GE; Tsikouris, EI; Tsoplifack, CB; Tsoumani, ME; Tsujimoto, R; Tsybin, YO; Tu, J; Tu, TM; Turco, M; Turkyilmaz, IB; Uddin, MJ; Ung, J; Unsihuay, D; Utsunomiya, T; Vagenende, B; Vaishnav, J; Valdes, C; Validad, MH; Valle, J; van Ginkel, MPH; van Grevenstein, WMU; Vanderpuye, V; Vasan, N; Vasilenko, EA; Vasques, GJ; Vavoulis, P; Verani, A; Veziroglu, E; Viegas, A; Vitali, MG; Vitsas, G; Voccio, JP; Vogiatzidis, C; Volow, A; Volpin, F; Vourvahis, M; Wagner, LI; Walkowiak, J; Wallace, R; Wallentin, L; Wan, D; Wan, L; Wan, T; Wang, C; Wang, F; Wang, FN; Wang, H; Wang, J; Wang, L; Wang, Q; Wang, S; Wang, T; Wang, W; Wang, X; Wang, XW; Wang, Y; Wang, YS; Wang, Z; Ward, J; Ward, L; Waseem, R; Watson, DF; Weber, P; Wehrmeister, FC; Wei, CH; Wei, H; Wei, L; Wei, Q; Wei, Y; Weinstock, RS; Weiss, M; Welborn, M; Wen, L; Wen, LM; Wen, Q; Wen, Z; Wesseling, P; Westerbergh, J; White, K; Wick, MP; Willems, S; Wiyasa, IWA; Wójciak, R; Wolkenhauer, O; Won, HH; Wong, J; Woo, YC; Wood, LS; Wu, CT; Wu, CY; Wu, D; Wu, G; Wu, J; Wu, K; Wu, M; Wu, Q; Wu, T; Wu, W; Wu, X; Wu, XT; Wu, Y; Xi, D; Xi, J; Xiang, W; Xiang, Y; Xiao, M; Xiao, Z; Xie, H; Xie, Q; Xie, S; Xie, X; Xing, M; Xing, YL; Xu, C; Xu, X; Xu, Y; Xu, Z; Xue, F; Xue, XD; Yaglioglu, HG; Yamada, H; Yamashita, M; Yan, W; Yan, Z; Yanardag, R; Yang, D; Yang, H; Yang, K; Yang, QQ; Yang, R; Yang, S; Yang, T; Yang, X; Yang, Y; Yao, H; Yao, Y; Yari, D; Yassin, MT; Ye, C; Ye, J; Ye, Q; Yildiz, EA; Ying, S; Yoon, H; Yu, D; Yu, K; Yu, N; Yu, PL; Yuan, C; Yuan, D; Yuan, LJ; Yuan, Z; Yuen, N; Zagatto, AM; Zakaria, Y; Zalewski, AM; Zamora, S; Zavorotinskaya, T; Zeid, JL; Zeinoun, T; Zeng, C; Zerby, HN; Zhan, X; Zhang, A; Zhang, D; Zhang, E; Zhang, F; Zhang, H; Zhang, J; Zhang, L; Zhang, M; Zhang, P; Zhang, Q; Zhang, QY; Zhang, RG; Zhang, S; Zhang, T; Zhang, X; Zhang, Y; Zhang, YY; Zhao, CK; Zhao, H; Zhao, J; Zhao, K; Zhao, Q; Zhao, S; Zhao, T; Zhao, XQ; Zhao, Y; Zhao, Z; Zheng, J; Zheng, L; Zheng, Y; Zhou, B; Zhou, G; Zhou, L; Zhou, T; Zhou, X; Zhu, C; Zhu, J; Zhu, Y; Zhu, ZQ; Zhuang, T; Zimmermannova, O; Zin, NNINM; Zisimos, K; Zoghebi, KA; Zonder, JA; Zou, C; Zwirner, J | 1 |
| Benzoni, N; Ellender, T | 1 |
| Du, W; Hu, J; Li, W; Li, Y; Liu, F; Wang, X; Xu, L; Yang, L; Yue, Q; Zhao, R | 1 |
| Balestrieri, A; Barcellona, D; Caocci, G; Castagnola, M; Cau, R; Coghe, F; Coni, P; D'Andrea, F; Faa, G; Fanni, D; Gerosa, C; La Nasa, G; Ledda, F; Marongiu, F; Orru, G; Piras, M; Ronchi, A; Saba, L; Suri, JS | 1 |
| Gu, J; Ji, Y; Lu, Y; Qian, Z; Qiu, M; Sun, W | 1 |
| Chen, Y; Ding, W; Guo, H; Sun, T; Zeng, M; Zhang, Y | 1 |
| Fang, XH; Pan, R; Shan, ZX; Wen, YH; Yan, YM; Yang, J; Zeng, N; Zhao, AZ; Zhu, JN | 1 |
| Bai, Y; Jiang, X; Liu, P; Meng, L; Su, X; Wang, S; Xin, Y; Yang, G; Zhang, H | 1 |
| Boss, GR; Casteel, DE; Cividini, F; Dalton, ND; Dillmann, WH; Gu, Y; Kalyanaraman, H; Peterson, KL; Pilz, RB; Schwaerzer, GK; Zhuang, S | 1 |
| Dou, W; Gramolini, A; Kuzmanov, U; Lai, BFL; Lu, RXZ; Radisic, M; Rafatian, N; Smith, JB; Sun, Y; Wang, EY; Wu, Q; Yazbeck, J; Zhang, XO | 1 |
| Ham, W; Kang, CW; Kang, H; Kim, J; Lee, WS; Ock, S | 1 |
| Li, JD; Wu, MP; Xu, X; Yan, C; Zhang, YS; Zhou, Q | 1 |
| Chen, D; Chen, F; Jin, L; Pan, T; Su, Y; Wan, M; Wang, X; Xu, Y; Ye, J; Zhang, H; Zhang, Y | 1 |
| Bounds, KR; Chatterjee, P; Gupta, S; Li, L | 1 |
| Cao, Y; Huang, J; Zhou, H; Zhu, L | 1 |
| Carretero, OA; Kumar, N; Liao, TD; Maheshwari, M; Peterson, EL; Romero, CA | 1 |
| Fu, B; Ma, X; Mu, C; Su, Y; Yu, F | 1 |
| Cheng, Z; Feng, X; Gao, E; Hu, J; Lin, J; Sun, D; Wang, H; Wang, S; Wang, T; Zhang, M | 2 |
| Deng, XL; Du, XJ; Gou, W; Hou, MC; Lai, BC; Lei, T; Ren, YJ; She, G; Wang, HF; Wang, Y | 1 |
| Andersen, ND; Cavanaugh, NB; Dyle, MC; Gensicke, NM; Huang, T; Qian, L; Turek, JW | 1 |
| Benedict, C; Cheng, Z; Cimini, M; de Lucia, C; Garikipati, VNS; Goukassian, DA; Kishore, R; Koch, WJ; Lucchese, AM; Roy, R; Truongcao, MM; Wang, C | 1 |
| Alreja, G; Guan, J; Joseph, J; Luptak, I; Metes-Kosik, N; Shi, J; Zhi, H | 1 |
| Du, J; Jia, LX; Li, HH; Li, YL; Qi, GM | 1 |
| Basu, R; Fan, D; Kandalam, V; Kassiri, Z; Lee, J; Oudit, GY; Patel, V; Takawale, A; Wang, X | 1 |
| Chen, Q; Huang, D; Huang, S; Lei, W; Pang, L | 1 |
| Guo, RW; Kuang, CW; Liu, B; Xi, YY; Yang, LX | 1 |
| Cardema, MC; Fiehn, O; Gardner, DG; Glenn, DJ; Grapov, D; Ni, W; Yeghiazarians, Y; Zhang, Y | 1 |
| Abd Elhameed, AG; Abu-Elsaad, NM; El-Karef, A; Ibrahim, TM | 1 |
| Fang, P; Geng, J; Li, Z; Liu, Q; Lu, D; Shan, Q; Wang, K; Wang, S; Wang, Y; Zhang, Q | 2 |
| Brandon-Warner, E; Bridges, CR; Fargnoli, AS; Hajjar, RJ; Katz, MG; Kendle, AP; Schrum, LW; Williams, RD | 1 |
| Bhimaraj, A; Celis, R; Cordero-Reyes, AM; Estep, JD; Flores-Arredondo, JH; Hamilton, DJ; Orrego, CM; Torre-Amione, G; Trevino, AR; Youker, KA | 1 |
| Cheng, QJ; Li, XX; Liu, CL; Wang, JH; Wang, YH; Yuan, CT | 1 |
| Chen, L; Chen, QH; Kang, LN; Li, GN; Li, R; Wu, H; Xie, J; Xu, B; Zhang, XL | 1 |
| Li, Y; Sun, L; Wang, Y; Yan, S; Yang, G; Yang, X; Yu, C | 1 |
| Fu, YH; Hu, ZQ; Lin, QX; Shan, ZX; Tang, CM; Wu, SL; Xiao, Z; Yang, M; Zhang, Z; Zheng, XL; Zhu, JN; Zhu, WS | 1 |
| Geng, J; Liu, Q; Lu, D; Shan, Q; Wang, K; Wang, S; Zhang, B; Zhang, Q | 1 |
| De Mello, WC; Gerena, Y | 1 |
| De Mello, WC | 2 |
| Cai, L; Hein, DW; Li, X; Marshall, JP; Prabhu, SD; Xiang, X; Zhou, G | 1 |
| Alitalo, K; Andersson, LC; Bry, M; Hassinen, IE; Helkamaa, T; Jeltsch, M; Karpanen, T; Kivelä, R; Leskinen, H; Liimatta, E; Merentie, M; Mervaala, E; Ollila, HM; Oresic, M; Paavonen, K; Seppänen-Laakso, T; Ylä-Herttuala, S | 1 |
| Lu, J; Sun, L; Yu, XJ; Zang, WJ; Zhang, CH | 1 |
| Chu, XY; Li, M; Lin, L; Ni, Q; Wang, ZL | 1 |
| Aizawa, Y; Gurusamy, N; Kodama, M; Muslin, AJ; Suzuki, K; Tachikawa, H; Thandavarayan, RA; Watanabe, K; Zhang, S | 1 |
| Kang, BY; Khan, JA; Mehta, JL; Ryu, S; Seung, KB; Shekhar, R | 1 |
| Crespo, MJ; Escobales, N; Ramos, JA; Santacana, GE | 1 |
| Czabanka, M; Eklund, L; Heljasvaara, R; Ilves, M; Janmey, P; Kerkelä, R; Leskinen, H; Peuhkurinen, K; Pihlajaniemi, T; Piuhola, J; Rasi, K; Ruskoaho, H; Rysä, J; Sormunen, R; Vajkoczy, P; Vuolteenaho, O | 1 |
| Buyandelger, B; Gunkel, S; Knöll, R; Ku, CH; Miocic, S; Ng, KE; Piotrowska, I | 1 |
| Belmokhtar, K; Bonnet, P; Eder, V; Khamis, G; Machet, MC; Vourc'h, P; Worou, ME | 1 |
| He, L; Hua, J; Li, Q; Ma, L; Yu, J; Zhou, J | 1 |
| Tsui, JK; Wong, NL | 1 |
| Cowling, RT; Greenberg, BH; Gurantz, D; Peng, J; Tran, V | 1 |
| Belloni, AS; Kreutz, R; Nussdorfer, GG; Paul, M; Pessina, AC; Rossi, GP; Seccia, TM | 1 |
| Azuma, J; Pastukh, V; Ricci, C; Schaffer, S; Solodushko, V | 1 |
| Zhuo, JL | 1 |
| Bathgate, RA; Du, XJ; Layfield, SL; Mak, J; Mookerjee, I; Samuel, CS; Tregear, GW; Unemori, EN | 1 |
| Saruta, T; Sato, A | 1 |
| Dor, V | 1 |
| Doi, K; Francis, GS; Fukamachi, K; Hail, MD; Hoercher, KJ; McCarthy, PM; Ootaki, Y; Schenk, S; Starling, RC; Young, JB | 1 |
| Blankesteijn, WM; Bornstein, P; Cleutjens, JP; Crijns, HJ; Daemen, MJ; Debets, JJ; Duisters, R; Evelo, CT; Heymans, S; Janssen, BJ; Pinto, YM; Pokharel, S; Porter, JG; Schroen, B; Sharma, U; Smits, JF; van Leeuwen, RE | 1 |
| De Mello, WC; Monterrubio, J | 1 |
| Bourassa, E; Falcón, BL; Katovich, MJ; Raizada, MK; Speth, RC; Stewart, JM; Sumners, C; Walter, G | 1 |
| Bandlow, N; Bavendiek, U; Bley, S; Drexler, H; Grote, K; Grothusen, C; Haverich, A; Luchtefeld, M; Schieffer, B; Selle, T; Strüber, M | 1 |
| Emanueli, C; Graiani, G; Lagrasta, C; Lanfrancone, L; Madeddu, P; Meloni, M; Migliaccio, E; Padura, IM; Pelicci, P; Quaini, F; Spillmann, F | 1 |
| Crespo, MJ; Escobales, N | 1 |
| Altieri, PI; Crespo, MJ; Escobales, N | 1 |
| Aizawa, Y; Gurusamy, N; Hirabayashi, K; Kodama, M; Ma, M; Muslin, AJ; Prakash, P; Watanabe, K; Zhang, S | 1 |
| Euler, G; Heger, J; Piper, HM; Schröder, D | 1 |
| Belmadani, S; Berecek, KH; Bernal, J; Dell'italia, L; Murphy-Ullrich, JE; Pallero, MA; Wei, CC | 1 |
| Deng, W; Yin, YH; Zhang, A | 1 |
| Tarazi, RC | 1 |
| Korner, PI | 1 |
| Bolte, HD | 1 |
| Kuroda, T; Shida, H | 1 |
| Brown, WC; Kremer, D; Lindop, G; Morton, JJ; Robertson, JI | 1 |
| Aumont, MC; Curien, ND; Gourgon, R; Merillon, JP; Motte, G; Neukirch, F; Prasquier, R | 1 |
| Rösen, P; Rösen, R; Rump, AF | 1 |
| Lambert, C; Massillon, Y; Meloche, S | 1 |
| Appay, MD; Bariety, J; Heudes, D; Hinglais, N; Michel, JB; Nicoletti, A; Philippe, M; Sassy-Prigent, C | 1 |
| Burtin, P; Carteaux, JP; Clavey, M; Dopff, C; Hottier, E; Levy, B; Mertes, PM; Pinelli, G; Villemot, JP | 1 |
| Kawaguchi, H; Kitabatake, A | 1 |
| Higaki, J; Kawaguchi, N; Kobayashi, R; Mikami, H; Nagano, M; Nakamura, F; Ogihara, T; Onishi, S | 1 |
| Brilla, CG; Matsubara, LS; Weber, KT | 1 |
| Fukamizu, A; Miyazaki, M; Murakami, K; Okunishi, H; Shiota, N; Takai, S | 2 |
| Fukao, M; Hattori, Y; Kanno, M; Kitabatake, A; Sakuma, I; Sato, A | 1 |
| Fukao, M; Hattori, Y; Kanno, M; Kitabatake, A; Okamoto, H; Sakuma, I; Sato, A; Tomioka, H; Watanabe, M | 1 |
| Díez, J; Fortuño, MA; Ravassa, S | 1 |
| Higaki, J; Matsumoto, K; Moriguchi, A; Morishita, R; Nakagami, H; Nakamura, T; Ogihara, T; Sakonjo, H; Taniyama, Y | 1 |
| Adler, GK; Kifor, I; Ochoa-Maya, MR; Rennke, HG; Rocha, R; Stier, CT; Williams, GH | 1 |
| Braunwald, E; Bristow, MR | 1 |
| Acton, S; Belagaje, R; Bloem, L; Dixon, J; Donaghue, M; Estridge, T; Jeyaseelan, R; Johnson, B; Kadambi, V; Matter, WF; Pickard, T; Stancato, L; Vlahos, CJ; Zhang, C | 1 |
| Andreoli, AM; Anversa, P; Chimenti, S; Fiordaliso, F; Kajstura, J; Leri, A; Li, B; Limana, F; Medow, MS; Nadal-Ginard, B | 1 |
| Azuma, J; Schaffer, S; Solodushko, V | 1 |
| Büsing, CM; Döhnert, G; Raute-Kreinsen, U | 1 |
| Bolte, HD; Cyran, J | 1 |
| Kato, M; Nagai, M; Nagano, M; Yang, J | 1 |
| Bumpus, FM; Fouad-Tarazi, FM; Healy, B; Hirakata, H; Husain, A; Khosla, M; Kumagai, H; Urata, H | 1 |
| Ferrario, C; Fouad-Tarazi, FM; Khosla, M; Kumagai, H | 1 |
| Autenrieth, G; Göldel, N; Knesewitsch, P; Werdan, K; Wilmanns, W | 1 |
| Angermann, C; Pongratz, D; Spes, C | 1 |
| Gomez, J; McCabe, RE; Zintel, HA | 1 |
| Kuroda, M; Morimoto, S; Murakami, M | 1 |
| Anderson, ST; Pitt, A | 1 |
| Hauss, WH; Müller, US; Schmitt, G | 1 |
| Horwitz, LD; Mullins, CB; Payne, RM | 1 |
| Ettinger, PO; Haider, B; Khan, MI; Lyons, MM; Oldewurtel, HA; Regan, TJ | 1 |
13 review(s) available for angiotensin ii and Cardiomyopathies, Primary
| Article | Year |
|---|---|
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses | 2021 |
Updates in Sepsis Resuscitation.
Topics: Angiotensin II; Anti-Bacterial Agents; Antioxidants; Ascorbic Acid; Blood Glucose; Blood Pressure; Cardiomyopathies; Cardiotonic Agents; Critical Illness; Emergency Service, Hospital; Enteral Nutrition; Fluid Therapy; Glucocorticoids; Hemodynamics; Humans; Organ Dysfunction Scores; Randomized Controlled Trials as Topic; Respiration, Artificial; Resuscitation; Sepsis; Vasoconstrictor Agents | 2020 |
Molecular pathways triggered by COVID-19 in different organs: ACE2 receptor-expressing cells under attack? A review.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Atrial Fibrillation; Blood Coagulation; Capillary Permeability; Cardiomyopathies; COVID-19; Cytokine Release Syndrome; Cytokines; Endothelium, Vascular; Fibroblasts; Fibrosis; Humans; Liver Cirrhosis; Myocarditis; Receptors, Coronavirus; Renin-Angiotensin System; SARS-CoV-2; Systemic Inflammatory Response Syndrome; Thrombosis; Virus Internalization | 2020 |
Role of 14-3-3 protein and oxidative stress in diabetic cardiomyopathy.
Topics: 14-3-3 Proteins; Angiotensin II; Animals; Apoptosis; Cardiomegaly; Cardiomyopathies; Diabetes Complications; Fibrosis; Humans; Myocardium; Oxidative Stress; Signal Transduction | 2009 |
Genetics of mechanosensation in the heart.
Topics: Angiotensin II; Animals; Cardiomyopathies; Connectin; Heart Failure; Humans; Intermediate Filaments; Mechanotransduction, Cellular; Muscle Proteins; Mutation; Myocardium; Polymorphism, Genetic; Protein Kinases; Renin-Angiotensin System; Sarcomeres; Sensation; Stress, Mechanical | 2011 |
Monocyte chemoattractant protein-1: a key mediator of angiotensin II-induced target organ damage in hypertensive heart disease?
Topics: Angiotensin II; Cardiomyopathies; Chemokine CCL2; Humans; Hypertension | 2004 |
Aldosterone-induced organ damage: plasma aldosterone level and inappropriate salt status.
Topics: Aldosterone; Angiotensin II; Animals; Cardiomyopathies; Fibrosis; Humans; Mice; Mice, Transgenic; Receptors, Mineralocorticoid; Renin-Angiotensin System; Sodium Chloride, Dietary; Sodium-Hydrogen Exchangers; Vasculitis | 2004 |
Renin, angiotensin, and cardiac lesions.
Topics: Angiotensin II; Animals; Arteriosclerosis; Cardiomyopathies; Catecholamines; Endothelium; Heart Ventricles; Humans; Hypertension; Myocardial Infarction; Myocardium; Neurotransmitter Agents; Protein Biosynthesis; Rabbits; Rats; Renin | 1980 |
The sixth Volhard Lecture: Causal and homoeostatic factors in hypertension.
Topics: Angiotensin II; Animals; Cardiac Output; Cardiomyopathies; Dogs; Hemodynamics; Homeostasis; Humans; Hypertension; Hypertension, Renal; Norepinephrine; Rabbits; Renal Artery Obstruction; Renin-Angiotensin System; Vascular Resistance; Vasopressins | 1982 |
Renin-angiotensin system in failing heart.
Topics: Angiotensin II; Angiotensinogen; Animals; Cardiomyopathies; Collagen; Extracellular Matrix; Gene Expression; Heart; Humans; Myocardium; Reference Values; Renin-Angiotensin System | 1995 |
[Apoptosis in hypertensive cardiopathy].
Topics: Adult; Angiotensin II; Animals; Apoptosis; Cardiomyopathies; Heart Diseases; Humans; Hypertension; Hypertrophy, Left Ventricular; Insulin-Like Growth Factor I; Middle Aged; Myocardium; Proto-Oncogene Proteins c-bcl-2; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Tumor Suppressor Protein p53 | 1999 |
Taurine-deficient cardiomyopathy: role of phospholipids, calcium and osmotic stress.
Topics: Angiotensin II; Animals; Calcium; Cardiomyopathies; Heart Failure; Humans; Muscle Proteins; Myocardium; Phospholipids; Taurine; Water-Electrolyte Balance | 2000 |
[Early diagnosis and treatment of hypertension and renal vascular hypertension].
Topics: Adolescent; Adult; Age Factors; Angiotensin II; Cardiomyopathies; Cerebrovascular Disorders; Diagnosis, Differential; Female; Heart Failure; Humans; Hypertension; Hypertension, Renal; Kidney Function Tests; Male; Middle Aged; Radioisotope Renography; Renin | 1969 |
3 trial(s) available for angiotensin ii and Cardiomyopathies, Primary
| Article | Year |
|---|---|
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses | 2021 |
Thymosin β4 Deficiency Exacerbates Renal and Cardiac Injury in Angiotensin-II-Induced Hypertension.
Topics: Acute Kidney Injury; Angiotensin II; Animals; Blood Pressure; Cardiomyopathies; Hypertension; Infusions, Intravenous; Male; Mice; Mice, Knockout; Microfilament Proteins; Random Allocation; Rats; Thymosin | 2018 |
A comparison of the effects of Trasicor (oxprenolol) and Inderal (propranolol) on left ventricular myocardial function.
Topics: 1-Propanol; Adolescent; Adult; Aged; Amino Alcohols; Angina Pectoris; Angiotensin II; Blood Pressure; Cardiac Catheterization; Cardiac Output; Cardiomyopathies; Catechols; Female; Heart Function Tests; Heart Rate; Heart Septal Defects, Atrial; Heart Ventricles; Humans; Male; Middle Aged; Mitral Valve Stenosis; Nitroglycerin; Placebos; Pulmonary Valve Stenosis | 1970 |
117 other study(ies) available for angiotensin ii and Cardiomyopathies, Primary
| Article | Year |
|---|---|
Attenuation of Myocardial Fibrosis Using Molecular Hydrogen by Inhibiting the TGF-β Signaling Pathway in Spontaneous Hypertensive Rats.
Topics: Angiotensin II; Animals; Cardiomyopathies; Collagen Type I; Fibrosis; Hydrogen; Myocardium; Procollagen; Rats; Rats, Inbred SHR; Signal Transduction; Superoxide Dismutase; Transforming Growth Factor beta; Transforming Growth Factor beta1 | 2022 |
Tranilast inhibits angiotensin II-induced myocardial fibrosis through S100A11/ transforming growth factor-β (TGF-β1)/Smad axis.
Topics: Angiotensin II; Cardiomyopathies; Cell Movement; Cell Survival; Cells, Cultured; Fibrosis; Humans; ortho-Aminobenzoates; S100 Proteins; Signal Transduction; Smad Proteins; Transforming Growth Factor beta1 | 2021 |
Continuous Infusion of Angiotensin IV Protects against Acute Myocardial Infarction via the Inhibition of Inflammation and Autophagy.
Topics: Angiotensin II; Animals; Apoptosis; Autophagy; Cardiomyopathies; Cells, Cultured; Inflammation; Male; Mice; Mice, Inbred C57BL; Myocardial Infarction; Myocytes, Cardiac; Oxidative Stress; Protective Agents; Rats | 2021 |
Uncaria Rhynchophylla attenuates angiotensin Ⅱ-induced myocardial fibrosis via suppression of the RhoA/ROCK1 pathway.
Topics: Angiotensin II; Animals; Blood Pressure; Cardiomyopathies; Hypertension; Mice; Mice, Inbred C57BL; Myocardium; rho-Associated Kinases; rhoA GTP-Binding Protein; Signal Transduction; Uncaria | 2022 |
MicroRNA-122-5p Aggravates Angiotensin II-Mediated Myocardial Fibrosis and Dysfunction in Hypertensive Rats by Regulating the Elabela/Apelin-APJ and ACE2-GDF15-Porimin Signaling.
Topics: Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Apelin; Cardiomyopathies; Fibrosis; Growth Differentiation Factor 15; Hypertension; Inflammation; MicroRNAs; Rats | 2022 |
Pharmacological activation of estrogenic receptor G protein-coupled receptor 30 attenuates angiotensin II-induced atrial fibrosis in ovariectomized mice by modulating TGF-β1/smad pathway.
Topics: Angiotensin II; Animals; Atrial Fibrillation; Cardiomyopathies; Female; Fibroblasts; Fibrosis; Heart Atria; Mice; Mice, Inbred C57BL; Receptors, Estrogen; Receptors, G-Protein-Coupled; Smad Proteins; Transforming Growth Factor beta1 | 2022 |
Epididymal white adipose tissue promotes angiotensin II-induced cardiac fibrosis in an exosome-dependent manner.
Topics: Adipose Tissue, White; Angiotensin II; Animals; Cardiomyopathies; Exosomes; Fibrosis; Mice; Mice, Inbred C57BL; MicroRNAs | 2022 |
Suppression of angiotensin II-activated NOX4/NADPH oxidase and mitochondrial dysfunction by preserving glucagon-like peptide-1 attenuates myocardial fibrosis and hypertension.
Topics: Angiotensin II; Animals; Cardiomyopathies; Fibrosis; Glucagon-Like Peptide 1; Hypertension; Linagliptin; Liraglutide; Mitochondria; NADPH Oxidase 4; Rats; Rats, Sprague-Dawley | 2022 |
PKN2 deficiency leads both to prenatal 'congenital' cardiomyopathy and defective angiotensin II stress responses.
Topics: Angiotensin II; Animals; Cardiomegaly; Cardiomyopathies; Female; Hypertension; Mice; Mice, Knockout; Myocardium; Myocytes, Cardiac; Pregnancy; Protein Kinase C | 2022 |
Angiotensin II Mediates Cardiomyocyte Hypertrophy in Atrial Cardiomyopathy via Epigenetic Transcriptional Regulation.
Topics: Angiotensin II; Atrial Fibrillation; Cardiomegaly; Cardiomyopathies; Chromatin; Epigenesis, Genetic; Humans; Myocytes, Cardiac; Signal Transduction | 2022 |
Diacerein alleviates Ang II-induced cardiac inflammation and remodeling by inhibiting the MAPKs/c-Myc pathway.
Topics: Angiotensin II; Animals; Anthraquinones; Cardiomegaly; Cardiomyopathies; Fibrosis; Heart Failure; Hypertension; Inflammation; Mice; Mice, Inbred C57BL; Myocardium; Myocytes, Cardiac; RNA; Ventricular Remodeling | 2022 |
Losartan attenuates sepsis-induced cardiomyopathy by regulating macrophage polarization via TLR4-mediated NF-κB and MAPK signaling.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Cardiomyopathies; Losartan; Macrophages; Mice; Mitogen-Activated Protein Kinases; NF-kappa B; Receptor, Angiotensin, Type 1; Sepsis; Toll-Like Receptor 4 | 2022 |
Integrin subunit β-like 1 mediates angiotensin II-induced myocardial fibrosis by regulating the forkhead box Q1/Snail axis.
Topics: Angiotensin II; Animals; Cardiomyopathies; Extracellular Matrix Proteins; Fibroblasts; Fibrosis; Integrins; Losartan; Mice; Myocardium; RNA, Small Interfering; Transforming Growth Factor beta1 | 2022 |
Angiotensin-(1-7) ameliorates sepsis-induced cardiomyopathy by alleviating inflammatory response and mitochondrial damage through the NF-κB and MAPK pathways.
Topics: Angiotensin II; Cardiomyopathies; Cells, Cultured; Humans; Mitogen-Activated Protein Kinases; NF-kappa B; Sepsis | 2023 |
Aloe-emodin ameliorated MI-induced cardiac remodeling in mice via inhibiting TGF-β/SMAD signaling via up-regulating SMAD7.
Topics: Aloe; Angiotensin II; Animals; Cardiomyopathies; Emodin; Fibrosis; Hypertrophy; Mice; Myocardial Infarction; Myocardium; Myocytes, Cardiac; Rats; Signal Transduction; Smad7 Protein; Transforming Growth Factor beta1; Ventricular Remodeling | 2023 |
A novel caffeic acid derivative prevents angiotensin II-induced cardiac remodeling.
Topics: Angiotensin II; Animals; Caffeic Acids; Cardiomyopathies; Collagen; Fibroblasts; Fibrosis; Myocardium; Transforming Growth Factor beta; Ventricular Remodeling | 2023 |
Characterization of a robust mouse model of heart failure with preserved ejection fraction.
Topics: Angiotensin II; Animals; Cardiomyopathies; Disease Models, Animal; Fibrosis; Heart Failure; Mice; Phenylephrine; Stroke Volume; Ventricular Function, Left | 2023 |
Inhibition of miR-25 Ameliorates Cardiac Dysfunction and Fibrosis by Restoring Krüppel-like Factor 4 Expression.
Topics: Angiotensin II; Animals; Calcium; Cardiomegaly; Cardiomyopathies; Fibrosis; Hypertension; Kruppel-Like Factor 4; Mice; Mice, Inbred C57BL; MicroRNAs; Myocytes, Cardiac | 2023 |
[mRNA Expression Profile Changes in Angiotensin-Ⅱ-Induced Atrial Myocardial Fibrosis in Rats].
Topics: Angiotensin II; Animals; Atrial Fibrillation; Cardiomyopathies; Collagen; Fibrosis; Male; Rats; Rats, Sprague-Dawley; RNA, Messenger | 2023 |
Steroidogenic acute regulatory protein/aldosterone synthase mediates angiotensin II-induced cardiac fibrosis and hypertrophy.
Topics: Adrenal Glands; Angiotensin II; Animals; Biomarkers; Biopsy; Cardiomegaly; Cardiomyopathies; Collagen; Cytochrome P-450 CYP11B2; Disease Models, Animal; Disease Susceptibility; Fibrosis; Immunohistochemistry; Macrophages; Male; Models, Biological; Myocardium; Myofibroblasts; Phosphoproteins; Rats; Receptor, Angiotensin, Type 1; Signal Transduction; Smad2 Protein; Smad3 Protein | 2020 |
When the CAR Targets Scar.
Topics: Angiotensin II; Animals; Cardiomyopathies; Disease Models, Animal; Fibrosis; Immunotherapy, Adoptive; Mice; Mice, Mutant Strains; Myocardium; Phenylephrine; Receptors, Chimeric Antigen | 2019 |
Quercetin Dihydrate inhibition of cardiac fibrosis induced by angiotensin II in vivo and in vitro.
Topics: Angiotensin II; Animals; Cardiomegaly; Cardiomyopathies; Collagen Type I; Collagen Type III; Disease Models, Animal; Disease Progression; Fibroblasts; Fibrosis; Male; Mice; Mice, Inbred C57BL; Myocardium; Quercetin; Rats | 2020 |
Therapeutic Targeting of Interleukin-11 Signalling Reduces Pressure Overload-Induced Cardiac Fibrosis in Mice.
Topics: Angiotensin II; Animals; Antibodies, Neutralizing; Aorta; Arterial Pressure; Cardiomyopathies; Collagen; Constriction; Disease Models, Animal; Fibronectins; Fibrosis; Hydroxyproline; Interleukin-11; Male; Mice, Inbred C57BL; Myocardium; Signal Transduction | 2021 |
C-C chemokine receptor 5 signaling contributes to cardiac remodeling and dysfunction under pressure overload.
Topics: Angiotensin II; Animals; Aorta, Thoracic; Cardiomyopathies; Cell Line; Chemokines, CC; Disease Models, Animal; Extracellular Signal-Regulated MAP Kinases; Female; Humans; Hypertrophy, Left Ventricular; Immunoglobulin G; Mice; Mice, Inbred C57BL; Myocytes, Cardiac; p38 Mitogen-Activated Protein Kinases; Rats; Receptors, CCR5; Signal Transduction; Ventricular Remodeling | 2021 |
Piperlongumine attenuates angiotensin-II-induced cardiac hypertrophy and fibrosis by inhibiting Akt-FoxO1 signalling.
Topics: Angiotensin II; Animals; Apoptosis; Cardiomegaly; Cardiomyopathies; Dioxolanes; Disease Models, Animal; Fibroblasts; Fibrosis; Heart Failure; Kruppel-Like Factor 4; Myocytes, Cardiac; Nerve Tissue Proteins; Phosphorylation; Proto-Oncogene Proteins c-akt; Rats; Signal Transduction | 2021 |
Nlrp3 Deficiency Alleviates Angiotensin II-Induced Cardiomyopathy by Inhibiting Mitochondrial Dysfunction.
Topics: Angiotensin II; Animals; Apoptosis; Cardiomyopathies; Cytokines; Electrocardiography; Fibrosis; Gene Deletion; Inflammasomes; Inflammation Mediators; Male; Mice, Inbred C57BL; Mice, Knockout; Mitochondria; Myocytes, Cardiac; NLR Family, Pyrin Domain-Containing 3 Protein; Oxidative Stress | 2021 |
Dickkopf 3: a Novel Target Gene of miR-25-3p in Promoting Fibrosis-Related Gene Expression in Myocardial Fibrosis.
Topics: Adaptor Proteins, Signal Transducing; Angiotensin II; Animals; Cardiomyopathies; Female; Fibrosis; Gene Expression; Male; Mice; Mice, Inbred C57BL; MicroRNAs; Smad3 Protein | 2021 |
Sulforaphane prevents angiotensin II-induced cardiomyopathy by activation of Nrf2 through epigenetic modification.
Topics: Angiotensin II; Animals; Cardiomyopathies; Epigenesis, Genetic; Gene Expression Regulation; Isothiocyanates; Male; Mice; Mice, Inbred C57BL; NF-E2-Related Factor 2; Oxidative Stress; Sulfoxides; Vasoconstrictor Agents | 2021 |
Constitutive protein kinase G activation exacerbates stress-induced cardiomyopathy.
Topics: Angiotensin II; Animals; Cardiomyopathies; Cyclic GMP-Dependent Protein Kinase Type I; Cyclic GMP-Dependent Protein Kinases; Mice; Mice, Inbred C57BL; Mice, Knockout; Myocytes, Cardiac; Ventricular Remodeling | 2022 |
An organ-on-a-chip model for pre-clinical drug evaluation in progressive non-genetic cardiomyopathy.
Topics: Angiotensin II; Animals; Cardiomyopathies; Cardiotonic Agents; Cell Line; Cell Survival; Coculture Techniques; Drug Evaluation, Preclinical; Fibroblasts; Fibrosis; Humans; Induced Pluripotent Stem Cells; Lab-On-A-Chip Devices; Losartan; Mice; Myocytes, Cardiac; Pilot Projects; Proteome; Proteomics; Recombinant Proteins; Relaxin; Ventricular Remodeling | 2021 |
IGF-1 protects against angiotensin II-induced cardiac fibrosis by targeting αSMA.
Topics: Actins; Angiotensin II; Animals; Cardiomyopathies; Cell Proliferation; Cells, Cultured; Disease Models, Animal; Fibroblasts; Fibrosis; Infusions, Intravenous; Insulin-Like Growth Factor I; Male; Mice, Inbred C57BL; Mice, Knockout; Myocytes, Cardiac; Phenylephrine; Proto-Oncogene Proteins c-akt; Rats; Receptor, IGF Type 1; rho-Associated Kinases; Signal Transduction | 2021 |
Vinpocetine Attenuates Pathological Cardiac Remodeling by Inhibiting Cardiac Hypertrophy and Fibrosis.
Topics: Angiotensin II; Animals; Cardiomegaly; Cardiomyopathies; Cell Proliferation; Cells, Cultured; Cyclic Nucleotide Phosphodiesterases, Type 1; Cytoprotection; Disease Models, Animal; Dose-Response Relationship, Drug; Extracellular Matrix; Extracellular Matrix Proteins; Fibroblasts; Fibrosis; Male; Mice, Inbred C57BL; Myocytes, Cardiac; Phosphodiesterase Inhibitors; Signal Transduction; Ventricular Remodeling; Vinca Alkaloids | 2017 |
Interleukin-6 deficiency attenuates angiotensin II-induced cardiac pathogenesis with increased myocyte hypertrophy.
Topics: Angiotensin II; Animals; Cardiomyopathies; Cells, Cultured; Hypertrophy; Interleukin-6; Male; Mice; Mice, Knockout; Myocytes, Cardiac; STAT3 Transcription Factor | 2017 |
MicroRNA-130a, a Potential Antifibrotic Target in Cardiac Fibrosis.
Topics: Angiotensin II; Animals; Blotting, Western; Cardiomyopathies; Cell Differentiation; Cells, Cultured; Disease Models, Animal; Fibroblasts; Fibrosis; Gene Expression Regulation; Humans; Immunohistochemistry; Male; Mice; Mice, Transgenic; MicroRNAs; Myocardium; Reverse Transcriptase Polymerase Chain Reaction; RNA; Up-Regulation | 2017 |
Erythropoietin alleviates post-resuscitation myocardial dysfunction in rats potentially through increasing the expression of angiotensin II receptor type 2 in myocardial tissues.
Topics: Angiotensin II; Animals; Biomarkers; Cardiomyopathies; Cardiopulmonary Resuscitation; Erythropoietin; Female; Gene Expression Regulation; Heart Arrest; Male; Myocardium; Rats; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Renin | 2018 |
Scoparone attenuates angiotensin II-induced extracellular matrix remodeling in cardiac fibroblasts.
Topics: Angiotensin II; Animals; Artemisia; Cardiomyopathies; Cell Differentiation; Cell Proliferation; Cells, Cultured; Collagen Type I; Coumarins; Extracellular Matrix; Fibroblasts; Fibronectins; Fibrosis; Myocardium; Myofibroblasts; Phytotherapy; Rats; Signal Transduction; Smad Proteins; Transforming Growth Factor beta1 | 2018 |
Mst1 knockout enhances cardiomyocyte autophagic flux to alleviate angiotensin II-induced cardiac injury independent of angiotensin II receptors.
Topics: Angiotensin II; Animals; Autophagy; Blotting, Western; Cardiomyopathies; Cells, Cultured; Hepatocyte Growth Factor; Mice; Mice, Knockout; Microscopy, Fluorescence; Myocytes, Cardiac; Proto-Oncogene Proteins; Real-Time Polymerase Chain Reaction; Receptors, Angiotensin | 2018 |
Cardiac-specific Mst1 deficiency inhibits ROS-mediated JNK signalling to alleviate Ang II-induced cardiomyocyte apoptosis.
Topics: Acetylcysteine; Angiotensin II; Animals; Apoptosis; Cardiomyopathies; JNK Mitogen-Activated Protein Kinases; Male; MAP Kinase Kinase Kinase 5; Mice; Mice, Inbred C57BL; Mice, Knockout; Myocytes, Cardiac; Phosphorylation; Protein Serine-Threonine Kinases; Reactive Oxygen Species; Signal Transduction; Thioredoxins | 2019 |
K
Topics: Angiotensin II; Animals; Blotting, Western; Cardiomyopathies; Fibroblasts; Fibrosis; Gene Expression Regulation; Heart Ventricles; Immunohistochemistry; Inflammation; Intermediate-Conductance Calcium-Activated Potassium Channels; Male; Monocytes; Myocardium; Myofibroblasts; Rats; Rats, Sprague-Dawley; RNA | 2019 |
Accelerated Marfan syndrome model recapitulates established signaling pathways.
Topics: Angiotensin II; Animals; Aorta; Aortic Aneurysm; Cardiomyopathies; Dilatation, Pathologic; Disease Models, Animal; Disease Progression; Extracellular Signal-Regulated MAP Kinases; Fibrillin-1; Genetic Predisposition to Disease; Heterozygote; Marfan Syndrome; Mice, Mutant Strains; Mutation; Myocardium; p38 Mitogen-Activated Protein Kinases; Phenotype; Phosphorylation; Signal Transduction; Smad2 Protein; Time Factors; Transforming Growth Factor beta | 2020 |
Podoplanin neutralization improves cardiac remodeling and function after acute myocardial infarction.
Topics: Angiotensin II; Animals; Antibodies, Neutralizing; Cardiomyopathies; Cell Survival; Cicatrix; Echocardiography; Fibrosis; Heart Failure; Heart Transplantation; Hemodynamics; Humans; Hypertrophy, Left Ventricular; Inflammation; Macrophages; Membrane Glycoproteins; Mice; Monocytes; Myocardial Infarction; Myocardial Ischemia; Myocytes, Cardiac; Regeneration; Vasoconstrictor Agents; Ventricular Function, Left; Ventricular Remodeling | 2019 |
Effects of direct Renin inhibition on myocardial fibrosis and cardiac fibroblast function.
Topics: Amides; Angiotensin II; Animals; Antihypertensive Agents; Cardiomyopathies; Collagen; Diet; Extracellular Matrix; Fibroblasts; Fibrosis; Fumarates; Homocysteine; Mice; Myocardium; Proto-Oncogene Proteins c-akt; Renin; Renin-Angiotensin System; Signal Transduction | 2013 |
Adiponectin suppresses angiotensin II-induced inflammation and cardiac fibrosis through activation of macrophage autophagy.
Topics: Adiponectin; Angiotensin II; Animals; Autophagy; Cardiomyopathies; Cells, Cultured; Enzyme-Linked Immunosorbent Assay; Fibrosis; Immunohistochemistry; In Vitro Techniques; Inflammation; Macrophages; Mice; Mice, Knockout; Real-Time Polymerase Chain Reaction | 2014 |
Differential role of TIMP2 and TIMP3 in cardiac hypertrophy, fibrosis, and diastolic dysfunction.
Topics: Angiotensin II; Animals; Cardiomegaly; Cardiomyopathies; Fibrosis; Heart Failure, Diastolic; Hypertrophy, Left Ventricular; Mice, Inbred C57BL; Mice, Knockout; Myocardium; Tissue Inhibitor of Metalloproteinase-2; Tissue Inhibitor of Metalloproteinase-3; Ventricular Remodeling | 2014 |
Effects of emodin and irbesartan on ventricular fibrosis in Goldblatt hypertensive rats.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Biphenyl Compounds; Blotting, Western; Cardiomyopathies; Collagen; Echocardiography; Emodin; Enzyme Inhibitors; Fibrosis; Heart Ventricles; Hydroxyproline; Hypertension, Renovascular; Hypertrophy, Left Ventricular; Irbesartan; Male; Matrix Metalloproteinase 2; Myocardium; Rats; Rats, Sprague-Dawley; Real-Time Polymerase Chain Reaction; RNA, Messenger; Tetrazoles | 2014 |
Changes in levels of angiotensin II and its receptors in a model of inverted stress-induced cardiomyopathy.
Topics: Angiotensin I; Angiotensin II; Animals; Cardiomyopathies; Disease Models, Animal; Female; Myocardium; Peptide Fragments; Rabbits; Receptors, Angiotensin; Renin-Angiotensin System; Stress, Physiological | 2014 |
Cardiac steatosis potentiates angiotensin II effects in the heart.
Topics: Angiotensin II; Animals; Cardiomyopathies; Cells, Cultured; Diacylglycerol O-Acyltransferase; Fibrosis; Heart Ventricles; Lipid Metabolism; Mice; Mice, Inbred DBA; Myocytes, Cardiac; Reactive Oxygen Species; Receptors, Transforming Growth Factor beta; Transforming Growth Factor beta2; Triglycerides | 2015 |
Yogurt Containing the Probacteria Lactobacillus acidophilus Combined with Natural Antioxidants Mitigates Doxorubicin-Induced Cardiomyopathy in Rats.
Topics: Angiotensin II; Animals; Antioxidants; Atrial Natriuretic Factor; Camellia sinensis; Carbazoles; Cardiomyopathies; Cardiotonic Agents; Carvedilol; Cholesterol; Cytokines; Daucus carota; Doxorubicin; Functional Food; Heart; Lactobacillus acidophilus; Lipid Peroxidation; Male; Malondialdehyde; Myocardium; Oxidative Stress; Probiotics; Propanolamines; Rats, Sprague-Dawley; Yogurt | 2015 |
Renal Denervation Findings on Cardiac and Renal Fibrosis in Rats with Isoproterenol Induced Cardiomyopathy.
Topics: Angiotensin II; Animals; Biomarkers; Cardiomyopathies; Cytokines; Denervation; Fibrosis; Heart Atria; Heart Ventricles; Inflammation Mediators; Isoproterenol; Kidney; Kidney Diseases; Male; Myocardium; Natriuretic Peptide, Brain; Peptide Fragments; Procollagen; Rats, Sprague-Dawley; Renin-Angiotensin System | 2015 |
Mitigation of myocardial fibrosis by molecular cardiac surgery-mediated gene overexpression.
Topics: Angiotensin II; Animals; Calcium; Cardiomyopathies; Collagen; Disease Models, Animal; Enzyme Induction; Fibronectins; Fibrosis; Genetic Therapy; Heart Failure; Hemodynamics; Male; Myocardial Infarction; Myocardium; Myofibroblasts; Receptor, Angiotensin, Type 1; Sarcoplasmic Reticulum Calcium-Transporting ATPases; Sheep; Time Factors; Transforming Growth Factor beta | 2016 |
Full Expression of Cardiomyopathy Is Partly Dependent on B-Cells: A Pathway That Involves Cytokine Activation, Immunoglobulin Deposition, and Activation of Apoptosis.
Topics: Angiotensin II; Animals; Apoptosis; B-Lymphocytes; Cardiomyopathies; Collagen; Cytokines; Disease Models, Animal; Fibroblasts; Fibrosis; Genetic Predisposition to Disease; Heart Failure; Hypertrophy, Left Ventricular; Immunoglobulin G; Magnetic Resonance Imaging; Male; Mice, Inbred C57BL; Mice, Knockout; Mice, Nude; Mice, SCID; Myocardium; NG-Nitroarginine Methyl Ester; Phenotype; Sialic Acid Binding Ig-like Lectin 2; Signal Transduction; Sodium Chloride; Stroke Volume; Time Factors; Ventricular Dysfunction, Left; Ventricular Function, Left; Ventricular Remodeling | 2016 |
MiR-30a regulates the atrial fibrillation-induced myocardial fibrosis by targeting snail 1.
Topics: 3' Untranslated Regions; Angiotensin II; Animals; Atrial Fibrillation; Binding Sites; Cardiomyopathies; Cell Adhesion Molecules; Cells, Cultured; Disease Models, Animal; Fibroblasts; Fibrosis; Gene Expression Regulation; Male; MicroRNAs; Myocardium; Rabbits; Rats, Sprague-Dawley; RNA, Messenger; Signal Transduction; Snail Family Transcription Factors; Time Factors; Transcription Factors; Transfection | 2015 |
Periostin expression induced by oxidative stress contributes to myocardial fibrosis in a rat model of high salt-induced hypertension.
Topics: Angiotensin II; Animals; Biomarkers; Blood Pressure; Cardiomyopathies; Cell Adhesion Molecules; Disease Models, Animal; Fibrosis; Gene Expression; Gene Expression Regulation; Hypertension; Male; Oxidative Stress; Rats; Reactive Oxygen Species; Sodium Chloride, Dietary | 2016 |
Renal denervation significantly attenuates cardiorenal fibrosis in rats with sustained pressure overload.
Topics: Aldosterone; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Biomarkers; Cardiomyopathies; Disease Models, Animal; Fibrosis; Heart Atria; Heart Ventricles; Humans; Kidney; Losartan; Myocardium; Natriuretic Peptide, Brain; Peptide Fragments; Procollagen; Rats; Rats, Sprague-Dawley; Renin-Angiotensin System; Sympathectomy | 2016 |
Effect of testosterone on the proliferation and collagen synthesis of cardiac fibroblasts induced by angiotensin II in neonatal rat.
Topics: Angiotensin II; Animals; Animals, Newborn; Cardiomyopathies; Cell Cycle; Cell Proliferation; Cells, Cultured; Collagen; Disease Models, Animal; Fibroblasts; MAP Kinase Signaling System; Myocardium; Phosphorylation; Rats; Testosterone | 2017 |
Targeting EZH1 and EZH2 contributes to the suppression of fibrosis-associated genes by miR-214-3p in cardiac myofibroblasts.
Topics: 3' Untranslated Regions; Angiotensin II; Animals; Binding Sites; Cardiomyopathies; Cells, Cultured; Collagen Type I; Collagen Type I, alpha 1 Chain; Collagen Type III; Disease Models, Animal; Enhancer of Zeste Homolog 2 Protein; Fibrosis; Gene Expression Regulation; Male; Mice, Inbred C57BL; MicroRNAs; Myocardium; Myofibroblasts; NF-kappa B; Oligonucleotides; Polycomb Repressive Complex 2; PPAR gamma; RNA Interference; Signal Transduction; Transfection | 2016 |
Renal Denervation Attenuates Multi-Organ Fibrosis and Improves Vascular Remodeling in Rats with Transverse Aortic Constriction Induced Cardiomyopathy.
Topics: Alanine Transaminase; Angiotensin II; Animals; Aorta; Blood Pressure; Carbazoles; Cardiomegaly; Cardiomyopathies; Carvedilol; Constriction; Cystatin C; Denervation; Fibrosis; Heart Rate; Kidney; Malondialdehyde; Natriuretic Peptide, Brain; Organ Specificity; Oxidative Stress; Peptide Fragments; Procollagen; Propanolamines; Rats, Sprague-Dawley; Superoxide Dismutase; Transforming Growth Factor beta1; Vascular Remodeling | 2016 |
Eplerenone inhibits the intracrine and extracellular actions of angiotensin II on the inward calcium current in the failing heart. On the presence of an intracrine renin angiotensin aldosterone system.
Topics: Aldosterone; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Calcium Signaling; Cardiomyopathies; Cricetinae; Eplerenone; Heart Failure; Mineralocorticoid Receptor Antagonists; Models, Cardiovascular; Receptor, Angiotensin, Type 1; Receptors, Mineralocorticoid; Renin-Angiotensin System; Spironolactone | 2008 |
Metallothionein reverses the harmful effects of angiotensin II on the diabetic heart.
Topics: Angiotensin II; Cardiomyopathies; Diabetic Angiopathies; Humans; Metallothionein; NADP; Oxidative Stress | 2008 |
Metallothionein suppresses angiotensin II-induced nicotinamide adenine dinucleotide phosphate oxidase activation, nitrosative stress, apoptosis, and pathological remodeling in the diabetic heart.
Topics: Angiotensin II; Animals; Apoptosis; Cardiomyopathies; Diabetes Mellitus, Experimental; Diabetic Angiopathies; Fibrosis; Hypertrophy; Metallothionein; Mice; Mice, Transgenic; Myocardium; Myocytes, Cardiac; NADP; Oxidative Stress; Ventricular Remodeling | 2008 |
Overexpression of vascular endothelial growth factor-B in mouse heart alters cardiac lipid metabolism and induces myocardial hypertrophy.
Topics: Angiotensin II; Animals; Blood Pressure; Capillaries; Cardiomegaly; Cardiomyopathies; Cell Size; Ceramides; Coronary Vessels; Disease Models, Animal; Heart Rate; Humans; Hypertension; Lipid Metabolism; Mice; Mice, Transgenic; Mitochondria, Heart; Myocardial Ischemia; Myocardium; Myocytes, Cardiac; Myosin Heavy Chains; Neovascularization, Physiologic; Oxidation-Reduction; Promoter Regions, Genetic; Skin; Time Factors; Triglycerides; Up-Regulation; Vascular Endothelial Growth Factor B; Ventricular Function, Left; Ventricular Myosins | 2008 |
Ameliorative effect of Captopril and Valsartan on an animal model of diabetic cardiomyopathy.
Topics: Angiotensin I; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Cardiomyopathies; Creatine Kinase, MB Form; Diabetes Mellitus, Experimental; Female; Isoenzymes; L-Lactate Dehydrogenase; Male; Microscopy, Electron; Myocardium; Rats; Rats, Sprague-Dawley; Renin-Angiotensin System; Tetrazoles; Valine; Valsartan | 2008 |
[Effects of Tangxinping Capsule on angiotensin II and its type 1 receptor and myocardial ultrastructure in diabetic rats].
Topics: Angiotensin II; Animals; Cardiomyopathies; Diabetes Mellitus, Experimental; Drugs, Chinese Herbal; Male; Myocardium; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; RNA, Messenger | 2008 |
Cell swelling, impulse conduction, and cardiac arrhythmias in the failing heart. Opposite effects of angiotensin II and angiotensin (1-7) on cell volume regulation.
Topics: Angiotensin I; Angiotensin II; Animals; Arrhythmias, Cardiac; Cardiomyopathies; Cell Size; Cells, Cultured; Cricetinae; Electrophysiology; Heart Conduction System; Heart Failure; Heart Ventricles; Hypotonic Solutions; Male; Membrane Potentials; Myocytes, Cardiac; Peptide Fragments; Pulse | 2009 |
Curcumin reduces angiotensin II-mediated cardiomyocyte growth via LOX-1 inhibition.
Topics: Angiotensin II; Animals; Cardiomyopathies; Cell Enlargement; Cells, Cultured; Curcumin; Growth Inhibitors; Mice; Myocytes, Cardiac; Receptor, Angiotensin, Type 1; Scavenger Receptors, Class E | 2010 |
Hemodynamic alterations in the coronary circulation of cardiomyopathic hamsters: age and Ang II-dependent mechanisms.
Topics: Aging; Angiotensin II; Animals; Cardiomyopathies; Coronary Circulation; Cricetinae; Heart Rate; Hemodynamics; Male; Mesocricetus | 2009 |
Collagen XV is necessary for modeling of the extracellular matrix and its deficiency predisposes to cardiomyopathy.
Topics: Age Factors; Aging; Angiotensin II; Animals; Atrial Natriuretic Factor; Cardiomyopathies; Collagen; Coronary Circulation; Disease Models, Animal; Echocardiography; Elasticity; Enzyme Inhibitors; Extracellular Matrix; Female; Gene Expression Profiling; Gene Expression Regulation; Genotype; Heart Ventricles; Hemodynamics; Hypertension; Male; Mice; Mice, 129 Strain; Mice, Inbred C57BL; Mice, Knockout; Microcirculation; Microscopy, Electron; Microscopy, Video; Myocardium; Natriuretic Peptide, Brain; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Phenotype; Polymerase Chain Reaction; RNA, Messenger; Telemetry; Ventricular Remodeling | 2010 |
Hemin decreases cardiac oxidative stress and fibrosis in a rat model of systemic hypertension via PI3K/Akt signalling.
Topics: Analysis of Variance; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Animals, Newborn; Antihypertensive Agents; Antioxidants; Apoptosis; Cardiomyopathies; Caspase 3; Cells, Cultured; Collagen Type I; Disease Models, Animal; Enzyme Activation; Fibrosis; Heme Oxygenase (Decyclizing); Hemin; Hemodynamics; Hypertension, Renovascular; Losartan; Male; Myocytes, Cardiac; NADPH Oxidases; Oxidative Stress; Oxidoreductases Acting on CH-CH Group Donors; p38 Mitogen-Activated Protein Kinases; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; rac1 GTP-Binding Protein; Rats; Rats, Wistar; rhoA GTP-Binding Protein; Signal Transduction; Time Factors; Ventricular Function, Left | 2011 |
Anti-fibrotic effect of Aliskiren in rats with deoxycorticosterone induced myocardial fibrosis and its potential mechanism.
Topics: Amides; Angiotensin II; Animals; Antihypertensive Agents; Blood Pressure; Blotting, Western; Cardiomyopathies; Cardiotonic Agents; Collagen; Desoxycorticosterone; Extracellular Signal-Regulated MAP Kinases; Fibrosis; Fumarates; Heart Ventricles; Indicators and Reagents; Male; Matrix Metalloproteinase 9; Myocardium; Radioimmunoassay; Rats; Rats, Sprague-Dawley; Renin | 2012 |
Upregulation of vasopressin V2 and aquaporin 2 in the inner medullary collecting duct of cardiomyopathic hamsters is attenuated by enalapril treatment.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Aquaporin 2; Aquaporin 6; Aquaporins; Arginine Vasopressin; Cardiomyopathies; Cricetinae; Cyclic AMP; Enalapril; Gene Expression; Kidney Medulla; Kidney Tubules, Collecting; Male; Receptors, Vasopressin; RNA, Messenger; Up-Regulation | 2002 |
Tumor necrosis factor-alpha-induced AT1 receptor upregulation enhances angiotensin II-mediated cardiac fibroblast responses that favor fibrosis.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Animals, Newborn; Cardiomyopathies; Cells, Cultured; Dose-Response Relationship, Drug; Enzyme Activation; Extracellular Matrix; Fibroblasts; Fibrosis; Imidazoles; Losartan; Matrix Metalloproteinase 2; Proline; Pyridines; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Tissue Inhibitor of Metalloproteinase-1; Tumor Necrosis Factor-alpha; Up-Regulation | 2002 |
Cardiac fibrosis occurs early and involves endothelin and AT-1 receptors in hypertension due to endogenous angiotensin II.
Topics: Angiotensin II; Animals; Animals, Genetically Modified; Antihypertensive Agents; Biphenyl Compounds; Bosentan; Cardiomyopathies; Dansyl Compounds; Disease Models, Animal; Endothelin-1; Fibrosis; Hypertension; Irbesartan; Male; Rats; Receptor, Angiotensin, Type 1; Receptors, Angiotensin; Receptors, Cell Surface; Sulfonamides; Tetrazoles; Time Factors; Vasoconstrictor Agents | 2003 |
Possible cause of taurine-deficient cardiomyopathy: potentiation of angiotensin II action.
Topics: Angiotensin II; Animals; Animals, Newborn; Apoptosis; bcl-2-Associated X Protein; beta-Alanine; Blotting, Western; Cardiomyopathies; Caspase 9; Caspases; Cells, Cultured; Enzyme Activation; In Situ Nick-End Labeling; JNK Mitogen-Activated Protein Kinases; Mitogen-Activated Protein Kinases; Myocytes, Cardiac; Protein Kinase C; Protein Kinase C-delta; Protein Kinase C-epsilon; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Rats; Taurine | 2003 |
Relaxin modulates cardiac fibroblast proliferation, differentiation, and collagen production and reverses cardiac fibrosis in vivo.
Topics: Amino Acid Sequence; Angiotensin II; Animals; Cardiomyopathies; Cell Differentiation; Cell Division; Cells, Cultured; Collagen; Cyclic AMP; Disease Models, Animal; Fibroblasts; Fibrosis; Matrix Metalloproteinases; Mice; Mice, Inbred C57BL; Mice, Knockout; Molecular Sequence Data; Muscle, Smooth, Vascular; Myocytes, Cardiac; Nerve Tissue Proteins; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, beta-2; Receptors, G-Protein-Coupled; Receptors, Peptide; Relaxin; RNA, Messenger; Transforming Growth Factor beta; Vasoconstrictor Agents | 2004 |
Left ventricular reconstruction: the aim and the reality after twenty years.
Topics: Angiotensin II; Biomarkers; Cardiac Surgical Procedures; Cardiomyopathies; Heart Failure; Heart Ventricles; Humans; Myocardial Ischemia; Natriuretic Peptide, Brain; Neurotransmitter Agents; Norepinephrine; Renin; Stroke Volume; Ventricular Function, Left | 2004 |
Neurohormonal response to left ventricular reconstruction surgery in ischemic cardiomyopathy.
Topics: Aged; Angiotensin II; Biomarkers; Cardiac Surgical Procedures; Cardiomyopathies; Female; Follow-Up Studies; Heart Failure; Heart Ventricles; Humans; Male; Middle Aged; Myocardial Ischemia; Natriuretic Peptide, Brain; Neurotransmitter Agents; Norepinephrine; Renin; Statistics as Topic; Stroke Volume; Treatment Outcome; Ventricular Function, Left | 2004 |
Thrombospondin-2 is essential for myocardial matrix integrity: increased expression identifies failure-prone cardiac hypertrophy.
Topics: Angiotensin II; Animals; Animals, Genetically Modified; Cardiac Output, Low; Cardiomyopathies; Collagenases; Disease Progression; Enzyme Precursors; Extracellular Matrix; Gelatinases; Gene Expression; Gene Expression Profiling; Genetic Predisposition to Disease; Heart Rupture; Humans; Hypertension; Hypertrophy, Left Ventricular; Matrix Metalloproteinase 9; Metalloendopeptidases; Mice; Mice, Knockout; Myocardium; Rats; Rats, Sprague-Dawley; Renin; Stroke Volume; Thrombospondins; Up-Regulation | 2004 |
Intracellular and extracellular angiotensin II enhance the L-type calcium current in the failing heart.
Topics: Adenosine Triphosphatases; Angiotensin I; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Angiotensins; Animals; Calcium Channels, L-Type; Calcium Signaling; Cardiomyopathies; Cells, Cultured; Cricetinae; Enalaprilat; Enzyme Activation; Extracellular Fluid; Intracellular Fluid; Losartan; Male; Mesocricetus; Myocytes, Cardiac; Protein Kinase C; Sarcoplasmic Reticulum; Staurosporine; Thapsigargin | 2004 |
Angiotensin II type 2 receptor gene transfer elicits cardioprotective effects in an angiotensin II infusion rat model of hypertension.
Topics: Angiotensin II; Angiotensin II Type 2 Receptor Blockers; Animals; Cardiomyopathies; Cardiotonic Agents; Disease Models, Animal; Female; Gene Transfer Techniques; Genetic Therapy; Genetic Vectors; Hypertension; Hypertrophy, Left Ventricular; Infusion Pumps, Implantable; Lentivirus; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 2 | 2004 |
Angiotensin II induces MMP-2 in a p47phox-dependent manner.
Topics: Angiotensin II; Animals; Cardiomyopathies; Cells, Cultured; Coronary Artery Disease; Coronary Vessels; Dose-Response Relationship, Radiation; Humans; In Vitro Techniques; Matrix Metalloproteinase 2; Mice; Mice, Inbred C57BL; Myocytes, Smooth Muscle; NADPH Oxidases; Phosphoproteins | 2005 |
Genetic deletion of the p66Shc adaptor protein protects from angiotensin II-induced myocardial damage.
Topics: Adaptor Proteins, Signal Transducing; Angiotensin II; Animals; Apoptosis; Capillaries; Cardiomyopathies; Cardiovascular System; Cell Count; Cell Cycle; Coronary Vessels; Endothelial Cells; Gene Deletion; Mice; Mice, Knockout; Myocardium; Myocytes, Cardiac; Phenotype; Protein Isoforms; Shc Signaling Adaptor Proteins; Src Homology 2 Domain-Containing, Transforming Protein 1; Stem Cells | 2005 |
Angiotensin II-dependent vascular alterations in young cardiomyopathic hamsters: role for oxidative stress.
Topics: Acetylcysteine; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Antioxidants; Aorta; Blood Pressure; Cardiomyopathies; Cricetinae; Disease Models, Animal; Losartan; Male; Mesocricetus; NADPH Oxidases; Oxidative Stress; Superoxides | 2006 |
Increased vascular angiotensin II binding capacity and ET-1 release in young cardiomyopathic hamsters.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Aorta, Thoracic; Binding, Competitive; Cardiomyopathies; Cricetinae; Disease Models, Animal; Disease Progression; Dose-Response Relationship, Drug; Endothelin A Receptor Antagonists; Endothelin-1; In Vitro Techniques; Losartan; Male; Mesocricetus; Peptides, Cyclic; Protein Binding; Receptor, Angiotensin, Type 1; Receptor, Endothelin A; Vasoconstriction; Vasoconstrictor Agents | 2006 |
Glycogen synthase kinase 3beta together with 14-3-3 protein regulates diabetic cardiomyopathy: effect of losartan and tempol.
Topics: 14-3-3 Proteins; Angiotensin II; Animals; Apoptosis; Blood Glucose; Body Weight; Cardiomegaly; Cardiomyopathies; Cyclic N-Oxides; Diabetes Complications; Endomyocardial Fibrosis; Glycogen Synthase Kinase 3; Losartan; Mice; Mice, Transgenic; Mitogen-Activated Protein Kinases; Myocardium; NFATC Transcription Factors; Organ Size; Oxidative Stress; Phosphorylation; Protein Transport; Signal Transduction; Spin Labels; Streptozocin | 2006 |
Angiotensin II stimulates apoptosis via TGF-beta1 signaling in ventricular cardiomyocytes of rat.
Topics: Angiotensin II; Animals; Apoptosis; Autocrine Communication; Blotting, Western; Cardiomyopathies; Cells, Cultured; GATA Transcription Factors; Heart Ventricles; Male; MAP Kinase Signaling System; Myocytes, Cardiac; p38 Mitogen-Activated Protein Kinases; Rats; Rats, Wistar; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Smad Proteins; Time Factors; Transcription Factor AP-1; Transforming Growth Factor beta1; Up-Regulation | 2006 |
A thrombospondin-1 antagonist of transforming growth factor-beta activation blocks cardiomyopathy in rats with diabetes and elevated angiotensin II.
Topics: Angiotensin II; Animals; Cardiomyopathies; Diabetes Mellitus, Experimental; Fibrosis; Hemodynamics; Humans; Male; Myocardium; Peptides; Rats; Rats, Inbred WKY; Smad2 Protein; Thrombospondin 1; Transforming Growth Factor beta | 2007 |
[Expression of angiotensin converting enzyme and angiotensin II receptor in rabbits with hyperthyroid cardiomyopathy].
Topics: Angiotensin II; Animals; Cardiomyopathies; Disease Models, Animal; Female; Hyperparathyroidism; Male; Myocardium; Peptidyl-Dipeptidase A; Rabbits; Random Allocation; Receptors, Angiotensin; RNA, Messenger | 2007 |
[Long-term therapy of tumor patients. Secondary cardiomyopathies (author's transl)].
Topics: Angiotensin II; Antineoplastic Agents; Breast Neoplasms; Cardiomyopathies; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Drug Interactions; Humans; Neoplasm Metastasis; Neoplasms; Pericardial Effusion | 1980 |
Angiotensin II-induced myocardial damage with a special reference to low cardiac output syndrome.
Topics: Angiotensin II; Animals; Cardiac Output, Low; Cardiac Surgical Procedures; Cardiomyopathies; Dogs; Kidney; Myocardium; Necrosis; Rabbits | 1983 |
Angiotensin-induced myocardial necrosis and renal failure in the rabbit: distribution of lesions and severity in relation to plasma angiotensin II concentration and arterial pressure.
Topics: Acute Kidney Injury; Angiotensin II; Animals; Blood Pressure; Cardiomyopathies; Heart Ventricles; Kidney Tubular Necrosis, Acute; Necrosis; Rabbits | 1981 |
The left ventricular end-systolic pressure-volume ratio. Studies during changes in load and inotropism in the human.
Topics: Adult; Angiotensin II; Blood Pressure; Cardiac Output; Cardiomyopathies; Female; Heart Ventricles; Humans; Male; Middle Aged; Myocardial Contraction; Nitroprusside; Pressure; Stroke Volume; Systole | 1981 |
The ACE-inhibitor captopril improves myocardial perfusion in spontaneously diabetic (BB) rats.
Topics: Analysis of Variance; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Glucose; Blood Pressure; Captopril; Cardiomyopathies; Dextrans; Diabetes Mellitus, Type 1; Diastole; Fluorescein-5-isothiocyanate; Fluorescent Dyes; Glycated Hemoglobin; Heart; Heart Rate; In Vitro Techniques; Myocardial Contraction; Perfusion; Rats; Rats, Inbred BB; Systole; Ventricular Function, Left | 1995 |
Upregulation of cardiac angiotensin II AT1 receptors in congenital cardiomyopathic hamsters.
Topics: Analysis of Variance; Angiotensin II; Animals; Antihypertensive Agents; Biphenyl Compounds; Cardiomyopathies; Cricetinae; Embryo, Mammalian; Heart Ventricles; Heterozygote; Imidazoles; In Vitro Techniques; Losartan; Male; Mesocricetus; Myocardium; Necrosis; Radioligand Assay; Receptors, Angiotensin; Tetrazoles; Up-Regulation | 1995 |
Left ventricular fibrosis in renovascular hypertensive rats. Effect of losartan and spironolactone.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Biochemical Phenomena; Biochemistry; Biphenyl Compounds; Cardiomyopathies; Collagen; Endomyocardial Fibrosis; Fibrosis; Hypertension, Renovascular; Hypertrophy, Left Ventricular; Imidazoles; Losartan; Microscopy, Polarization; Polymerase Chain Reaction; Rats; Rats, Wistar; RNA, Messenger; Spironolactone; Tetrazoles | 1995 |
Right ventricular function following heart transplantation in relation to donor and recipient hemodynamic status and hormonal changes (vasopressin, renin, angiotensin II, aldosterone).
Topics: Adult; Aldosterone; Angiotensin II; Cardiomyopathies; Cardiomyopathy, Dilated; Heart Transplantation; Hemodynamics; Humans; Middle Aged; Postoperative Period; Renin; Renin-Angiotensin System; Tissue Donors; Vasopressins; Ventricular Function, Right | 1995 |
Chronic administration of angiotensin II receptor antagonist, TCV-116, in cardiomyopathic hamsters.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Benzimidazoles; Biphenyl Compounds; Cardiomyopathies; Cricetinae; Guinea Pigs; Hypertrophy; Male; Mesocricetus; Myocardium; Pressure; Renin-Angiotensin System; Tetrazoles; Ventricular Function, Left | 1994 |
Antifibrotic effects of spironolactone in preventing myocardial fibrosis in systemic arterial hypertension.
Topics: Aldosterone; Angiotensin II; Animals; Cardiomyopathies; Fibrosis; Hyperaldosteronism; Hypertension; Hypertension, Renovascular; Male; Potassium; Rats; Rats, Sprague-Dawley; Sodium; Spironolactone | 1993 |
Activation of angiotensin II-forming chymase in the cardiomyopathic hamster heart.
Topics: Amino Acid Sequence; Angiotensin II; Animals; Base Sequence; Cardiomyopathies; Chymases; Cricetinae; Enzyme Activation; Humans; Male; Mesocricetus; Molecular Sequence Data; Myocardium; Peptidyl-Dipeptidase A; Rats; RNA, Messenger; Serine Endopeptidases | 1997 |
Cloning of the gene and cDNA for hamster chymase 2, and expression of chymase 1, chymase 2 and angiotensin-converting enzyme in the terminal stage of cardiomyopathic hearts.
Topics: Amino Acid Sequence; Angiotensin II; Animals; Base Sequence; Blotting, Southern; Cardiomyopathies; Chymases; Cloning, Molecular; Cricetinae; Humans; Mice; Molecular Sequence Data; Myocardium; Peptidyl-Dipeptidase A; Polymerase Chain Reaction; Rats; RNA, Messenger; Serine Endopeptidases | 1998 |
A role of myofilament Ca2+ sensitivity in enhanced vascular reactivity in cardiomyopathic hamsters.
Topics: Actin Cytoskeleton; Angiotensin II; Animals; Aorta; Calcium; Calcium Channel Blockers; Cardiomyopathies; Cricetinae; Indoles; Male; Mesocricetus; Muscle Contraction; Muscle, Smooth, Vascular; Naphthalenes; Nifedipine; Phenylephrine; Phorbol 12,13-Dibutyrate; Potassium; Ryanodine; Staurosporine; Vasoconstrictor Agents | 1998 |
Effect of prolonged treatment with amlodipine on enhanced vascular contractility in cardiomyopathic hamsters.
Topics: Actin Cytoskeleton; Amlodipine; Angiotensin II; Animals; Aorta; Calcium; Cardiomyopathies; Cricetinae; Dose-Response Relationship, Drug; Isometric Contraction; Mesenteric Arteries; Muscle, Smooth, Vascular; Phenylephrine; Potassium; Time Factors; Vasoconstriction; Vasodilator Agents | 1999 |
Potential contribution of a novel antifibrotic factor, hepatocyte growth factor, to prevention of myocardial fibrosis by angiotensin II blockade in cardiomyopathic hamsters.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Cardiomyopathies; Cells, Cultured; Collagen; Cricetinae; Extracellular Matrix; Fibroblasts; Fibrosis; Hepatocyte Growth Factor; Humans; Imidazoles; In Vitro Techniques; Male; Matrix Metalloproteinase 1; Muscle Fibers, Skeletal; Myocardium; Olmesartan Medoxomil; Rats; Tetrazoles; Thiazepines; Ventricular Remodeling | 2000 |
Aldosterone: a mediator of myocardial necrosis and renal arteriopathy.
Topics: Adrenalectomy; Aldosterone; Angiotensin II; Animals; Blood Pressure; Cardiomyopathies; Enzyme Inhibitors; Eplerenone; Hormone Antagonists; Kidney; Male; Myocardium; Necrosis; NG-Nitroarginine Methyl Ester; Rats; Rats, Wistar; Renal Artery; Renin; Sodium Chloride; Spironolactone; Vascular Diseases | 2000 |
Congestive heart failure: fifty years of progress.
Topics: Angiotensin II; Apoptosis; Calcium; Cardiomegaly; Cardiomyopathies; Cytokines; Heart Failure; History, 20th Century; Humans; Models, Cardiovascular; Myocardial Contraction; Myocardial Ischemia; Signal Transduction | 2000 |
Role of PRL-3, a human muscle-specific tyrosine phosphatase, in angiotensin-II signaling.
Topics: Amino Acid Substitution; Angiotensin II; Calcium; Calcium Signaling; Cardiomyopathies; Cell Division; Cell Line; Chromatography, Affinity; Cloning, Molecular; Cytosol; Enzyme Inhibitors; Escherichia coli; Gene Library; Humans; Immediate-Early Proteins; Muscle, Skeletal; Mutagenesis, Site-Directed; Myocardium; Neoplasm Proteins; Organ Culture Techniques; Organometallic Compounds; Phenanthrolines; Protein Tyrosine Phosphatases; Recombinant Proteins; Signal Transduction; Transfection; Vanadates | 2001 |
IGF-1 overexpression inhibits the development of diabetic cardiomyopathy and angiotensin II-mediated oxidative stress.
Topics: Angiotensin II; Animals; Apoptosis; Cardiomyopathies; Diabetic Angiopathies; DNA; Insulin-Like Growth Factor I; Mice; Mice, Transgenic; Myocardium; Oxidative Stress; Reactive Oxygen Species; Renin-Angiotensin System; Tissue Distribution; Tumor Suppressor Protein p53; Tyrosine; Ventricular Function | 2001 |
[Experimentally induced heart muscle fiber necroses after premedication with strophanthin (author's transl)].
Topics: Angiotensin II; Animals; Cardiomyopathies; Female; Mitochondria, Muscle; Myocardium; Myofibrils; Necrosis; Rats; Strophanthins | 1976 |
[Diagnostic significance of the angiotensin infusion test as functional test of ventricular myocardium].
Topics: Angiotensin II; Cardiac Catheterization; Cardiomyopathies; Heart Function Tests; Humans; Myocardial Contraction | 1976 |
Protective effect of ACE- and kininase-inhibitor on the onset of cardiomyopathy.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Cardiomyopathies; Cholinesterase Inhibitors; Cricetinae; Enalapril; Mesocricetus; Prostaglandins | 1991 |
Angiotensins and the failing heart. Enhanced positive inotropic response to angiotensin I in cardiomyopathic hamster heart in the presence of captopril.
Topics: Angiotensin I; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensins; Animals; Captopril; Cardiac Output, Low; Cardiomyopathies; Cricetinae; Drug Synergism; Heart; Male; Mesocricetus; Myocardial Contraction; Myocardium; Receptors, Angiotensin | 1990 |
Biological activity of angiotensin-(1-7) heptapeptide in the hamster heart.
Topics: Angiotensin I; Angiotensin II; Animals; Cardiac Output; Cardiomyopathies; Coronary Circulation; Cricetinae; Heart; Male; Mesocricetus; Peptide Fragments; Perfusion; Pressure; Reference Values | 1990 |
[Echocardiography with angiotensin administration in the diagnosis of adriamycin-induced cardiomyopathy].
Topics: Adolescent; Adult; Angiotensin II; Cardiomyopathies; Dose-Response Relationship, Drug; Doxorubicin; Echocardiography; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Neoplasms | 1989 |
[Cardiac manifestation of progressive muscular dystrophy of the Duchenne type].
Topics: Adolescent; Adult; Angiotensin II; Cardiac Output; Cardiomyopathies; Child; Child, Preschool; Echocardiography; Electrocardiography; Exercise Test; Humans; Muscular Dystrophies; Myocardial Contraction | 1986 |
The effect of transient renal anoxia and portacaval transposition on canine arterial blood pressure.
Topics: Angiotensin II; Animals; Blood Pressure; Cardiomyopathies; Dogs; Hypertension; Hypoxia; Kidney; Kidney Diseases; Organ Size; Portacaval Shunt, Surgical; Portal Vein; Radiography; Renal Artery | 1968 |
[Development of connective tissue proliferation in the myocardium following the effect of various pathogenic stimuli].
Topics: Angiotensin II; Animals; Cardiomyopathies; Cell Division; Connective Tissue; Humans; Hypertension; Myocardium; Rats; Rats, Inbred Strains; Stress, Psychological; Tritium | 1971 |
Comparison of isometric exercise and angiotensin infusion as stress test for evaluation of left ventricular function.
Topics: Angiotensin II; Arteriosclerosis; Blood Pressure; Cardiac Catheterization; Cardiac Output; Cardiomyopathies; Coronary Disease; Evaluation Studies as Topic; Heart; Heart Diseases; Heart Rate; Humans; Myocardium; Oxygen Consumption; Physical Exertion; Stress, Physiological | 1973 |
Myocardial function and lipid metabolism in the chronic alcoholic animal.
Topics: Alcoholism; Angiotensin II; Animals; Blood Pressure; Carbon Radioisotopes; Cardiac Volume; Cardiomyopathies; Cell Membrane; Diet; Disease Models, Animal; Dogs; Ethanol; Heart; Heart Ventricles; Humans; Lipid Metabolism; Male; Myocardium; Oleic Acids; Phospholipids; Triglycerides; Vitamins; Water-Electrolyte Balance | 1974 |